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ADVANCED RECTAL CANCER: 
ASPECTS OF TREATMENT 

Stellingen 
behorende bij het proefschrift 
Advanced rectal cancer: 
Aspects of treatment 
L.M.D. Buhre 
Groningen, 14 september 1994 
1. Rectal cancer should be treated by experts. 
2. De behandeling van een patient met een rectumcarcinoom client 
voor alles gericht te zijn op het voorkomen van een lokaal 
recidief. 
3. Elke chirurg die resectie van een rectumcarcinoom overweegt 
client pre-operatief persoonlijk een "starre" rectoscopie te 
verrichten om grootte, lokalisatie, mate van fixatie en infiltratie 
te beoordelen. 
4. Het uitvoeren van een sfinctersparende ingreep ten koste van de 
radicaliteit of de kwaliteit van COJ?.tinentie is een kunstfout. 
5. Het belang van de exploratieve laparotomie bij de behandeling 
van het rectumcarcinoom wordt onderschat. 
6. Rectal cancer discriminates the male. 
7. De behandeling van een patient met een oncologische aandoening 
vraagt een multidisciplinaire aanpak waarin met name de huisarts 
client te participeren. 
8. "De waarheid" verschilt voor patient en arts; dit client steeds in de 
behandeling te worden verdisconteerd. 
9. Bij patienten met een depressie bestaat onvoldoende aandacht 
voor sexuele functiestoornissen zoals deze voortkomen uit ziekte 
en medicamenteuze behandeling. 
10. Een beleid dat binnen de werksituatie gericht is op het vroegtijdig 
opsporen van structured verzuim zal eerder een toename clan een 
afname van verzuim tot gevolg hebben. 
11. Voorstelling van zaken die slechts berusten op een logische 
gedachtengang zijn geheel verstoken van realiteit (Einstein). 
12. Naar mate meer dieren verdwijnen zal de mens leven 1n een 
steeds grotere eenzaamheid van geest. 
13. In zijn vrienden vindt de mens zijn bestaan. 
14. Wees niet te stellig. 
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2 Advanced rectal cancer 
This thesis is based on the experience gained from the treatment of patients with rectal 
cancer in the Division of Surgical Oncology, Department of Surgery, University Hospital 
of Groningen. Most operations were performed by residents under supervision of one and 
the same surgeon. Some general introductory remarks emphasize basic facts about the 
behaviour of rectal cancer, its treatment, the problems of residual and recurrent rectal 
cancer in the pelvis and adjuvant therapy. 
1 BIOLOGICAL BERA VIOUR OF RECTAL CANCER 
Familiarity with the pattern of growth and spread of rectal cancer and proper staging of the 
tumour are the cornerstones of the design of an optimal treatment strategy. A profound 
knowledge of local infiltration, lymphatic dissemination and haematogenous spread is of 
paramount importance to asses the problem and to make the right decisions. These three 
topics will be briefly discussed. 
1. 1 Local growth of rectal cancer 
Adenocarcinomas of colon and rectum in general are slowly growing processes. Their 
doubling time varies between 135 and llOO days with a mean of 620 days. 1 The vast 
majority originate from a pre-existing polyp. These adenocarcinomas start in the mucosa 
as an in situ carcinoma and sooner or later penetrate through the muscularis mucosae to 
become invasive cancers.2 Infiltration towards the serosal surface or perirectal fat progresses 
faster than the extension of the tumour in the longitudinal axis of the bowel. The 
macroscopic intramural extension of the tumour needs about half a year to invade a quarter 
of the circumference of the bowel. 3 The long doubling time and the slow growth of rectal 
cancers may explain some cases of long survival even after a resection that was not curative, 
or with proven hepatic metastases. 
Progression of the growth of the tumour not only increases the tumour volume but results 
in deeper penetration in the bowelwall. Contact with the lymphatics is established as soon 
as the tumour extends through the muscularis mucosae and may subsequently give rise to 
nodal metastases. At a later stage haematogenous spread can be initiated by invasion of 
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bloodvessels. 
Longitudinal intramural growth and infiltration into the rectal wall have important 
therapeutical consequences. The intramural extension of the rectal cancer is especially 
important when sphincter saving procedures are contemplated. The distal margin of 
resection should be free of tumour invasion. The presence of microscopic tumour 12 cm 
below the macroscopic margin of a rectal cancer has been described.4 However, microscopic 
intramural extension of rectal cancer usually is limited to within 2 cm from the 
macroscopic edge of the tumour.s Unexpected intramural extension of the tumour ca_n 
originate from retrograde carcinomatous lymphangitis in the rectal wall. Massive invasion 
of nodes along the inferior mesenteric artery can divert the lymphatic flow in caudal 
direction and towards the pelvic sidewalls. This intramural carcinomatous lymphangitis can 
be responsible for unexpected caudal extension of the tumour and irradicality at the 
resection margin. 6 This phenomenon often occurs with undifferentiated cancers as they have 
the reputation to metastasise at an early stage. 
Progression of tumour growth through the full thickness of the rectal wall also has 
important therapeutical consequences. Tumours seated in the upper third of the rectum, the 
intraperitoneal part, behave as colonic cancers and radical surgery is rather easy to perform. 
Their counterparts in the lower 2 / 3 of the rectum, however, behave differently since 
progressive growth through the rectal wall means invasion of the perirectal fat or adjacent 
structures. Inflammatory reaction in the periphery of the tumour can cause adhesions to 
surrounding structures. These inflammatory adhesions are the pathway for tumour 
invasion. 7'8 The aspect of the contact surface between the tumour and the surrounding 
tissues is an indicator for the aggressiveness of the tumour progression. A "pushing margin" 
as described by Spratt and Spjut would be specific for a slowly progressing tumour with a 
5- and 10-year survival of 46 and 370/o.9 A fast growing process can be identified by an 
"infiltrating margin", the expected 5- and 10-year survival are respectively 28 and 170/o. The 
absence of inflammatory reaction in the periphery of a rectal cancer is a sign of poor 
prognosis.9 Quirke investigated the circumferential spread of rectal cancer and its 
consequences for the risk of local recurrence. 10 Infiltration in the rectovaginal septum or the 
uterus can have grave consequences when the extent of the rectal resection in the anterior 
direction is not adapted accordingly. In the male, tumour progression into the anterior 
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direction can progress through Denonvilliers' fascia into the seminal vesicles and / or the 
prostate. Tumour infiltration in dorsal direction can lead to invasion of Walldeyers fascia 
and even the sacrum, thus making the tumour less accessible to radical resection. Lateral 
extension of the tumour towards the pelvic sidewalls can result in fixation to the obturator 
fossa, the iliac vessels or ureter. Failure to detect this extrarectal tumour extension and to 
act accordingly will inevitably result in inadequate surgery and hence pelvic recurrence with 
all the grim consequences. 
1.2 Lymphatic spread 
Adequate selection of the treatment strategy of rectal cancer is impossible without profound 
knowledge of its lymphatic spread. Already in 1925 Villemin identified a "watershed" in the 
lymphatic drainage of the rectum at the level of the anterior peritoneal reflection.11 
Tumours seated in the intraperitoneal portion of the rectum, above this "watershed" drain 
via the lymphatics and the nodes following the inferior mesenteric vessels. 12 Lymphatic 
spread of these intraperitoneal rectal cancers towards the pelvic sidewalls or in caudal 
direction takes only place when the lymphatic flow is reversed due to massive tumour 
invasion in the mesenteric nodes. 13 
For tumours localised below the anterior peritoneal reflection, in the pelvic portion of the 
rectum, the lymphatic spread is more complex. The predilective drainage is in cranial 
direction towards the mesentery. However, there is additional lateral drainage towards the 
nodes of the hypogastric chain via the lymphatics in the lateral stalks of the rectum and the 
nodes following the middle rectal artery. 
From the nodes of the rectal mesentery and the hypogastric chain lymphatic metastases can 
reach the cystema chyli, the thoracic duct, the supraclavicular nodes and finally the 
bloodstream. 
1.3 Haematogenic metastases 
The principal venous drainage of the rectum takes place via the inferior mesenteric vein 
and the portal system. This is the major pathway for tumour seeding towards the liver and 
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the lungs. The lower third of the rectum has additional venous drainage towards the caval 
system via the middle and inferior rectal vein, thus being the origin of direct haematogenic 
spread to the lungs by bypassing the liver.
14 The visceral vessels of the rectum have 
connections with the presacral and prevertebral venous plexus, a third route for vascular 
dissemination. The prevertebral venous plexus is a low pressure system without valves and 
can be the pathway for dissemination in the sacral and lumbar vertebrae. 
2 CURATIVE TREATMENT OF RECTAL CANCER 
The stage of the rectal cancer at presentation is not only important for the chances of cure 
but will determine whether lesser surgery or a major procedure will be required to provide 
cure. When diagnosed at an early stage the depth of invasion is often limited (Tl) and 
modalities of local treatment can offer cure. Rectal cancers with a deeper penetration into 
the rectal wall (T2 or T3) may have lymphatic metastases into regional nodes and need 
adequate locoregional treatment. Any modality for local treatment carries the risk ofleaving 
metastases in the pararectal lymph nodes or higher up. 
2.1 Local treatment of rectal cancer 
The criteria a rectal cancer should fulfil for local therapy with curative intent depend from 
the modality used. The general rule, however, is that local therapy with curative intent 
should only be contemplated in the absence of any suspicion or likelihood of lymphatic 
dissemination. Histologic investigation of the biopsy should show a well differentiated 
adenocarcinoma. Undifferentiated and mucinous adenocarcinomas have a tendency to 
metastasise at an early stage and are not suitable for local therapy with curative intent. 
Technical problems limit the use of local therapy to the lower 2 / 3 of the rectum, the 
pelvic rectum. 
2.1.1 Local Radiotherapy 
One of the techniques uses a 50 KV contact radiotherapy machine outfitted with an X-ray 
tube with a focal length of 4 cm. The depth of penetration of the ionising beam is limited, 
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the 900/o isodose line being at 2 cm below the surface. The output of this machine is about 
20 Gy per minute and a single dose of 30 Gy is given per session. This so called 
endocavitary radiotherapy can be given on outpatient base and can be repeated every three 
weeks with a total tumourdose up to 80 to 150 Gy. 15 
A specially designed rectoscope is introduced in the rectum after anal dilatation under local 
anaesthesia. The rectoscope is centered around the tumour and the X-ray tube is introduced 
for the treatment. The diameter of the tube being 3 cm, the tumour should be smaller in 
order to be adequately exposed to the radiation. Larger tumours sometimes are irradiated 
with overlapping fields, a compromise that may be detrimental to the end result. 
Brachytherapy by means of afterloading with Iridium is a second radiotherapeutical 
modality. This technique can be used for tumours of which the thickness precludes the use 
of endocavitary radiotherapy. 16 
2.1.2 Local Excision of Rectal Cancer 
The transsphincteric approach has been propagated for the local excision of rectal cancers.17 
The risk of implantation of viable exfoliated tumourcells into the perirectal fat or the 
restored sphincter is a major disadvantage. With the advent of circular staplers, allowing 
very low anterior resections, the transphincteric approach is seldom used any more. 
Nowadays local excision almost always is carried out transanally. 
This technique should be limited to well-differentiated exophytic tumours covering less than 
l / 3 of the circumference of the rectum. A 0.5 cm margin of normal tissue around the 
tumour and sufficient margin at the base are required. 18•19 
2.1.3 Electrocoagulation of Rectal Cancer 
Electrocoagulation of rectal cancer with curative purpose has been developed in the U.S by 
Strauss20 and in the Netherlands by Wassink.21 This technique uses alternating current to 
"boil" the tumour away through a large bore perspex rectoscope.22 Tumours should meet 
strict criteria in order to be eligible for electrocoagulation with curative purpose. The 
growth should be a well-differentiated adenocarcinoma seated below the peritoneal reflection 
and have an exophytic growth pattern. Coagulation of tumours covering more than l / 3 
of the circumference may lead to rectal stricture. Proximity of the posterior vaginal wall 
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carries the risk of an iatrogenic recto-vaginal fistula. Electrocoagulation close to the dentate 
line may result in scarring and disturbed continence. Electrocoagulation for cure should 
only be used in a strictly selected group of patients. Extreme caution is mandatory and the 
possibility of unsuspected lymphatic spread should be taken into consideration.ZJ 
2.2 Radical locoregional resection for rectal cancer 
2.2.1 Technique of the resection of the rectosigmoid colon 
Following induction of anaesthesia the rectum is irrigated with saline solution by means of 
a Pezzar catheter till the returning fluid is clear. Subsequently the rectum is filled with 100/o 
PVP iodine solution for bactericidal and cytotoxic purposes. After the introduction of an 
indwelling catheter the patient is draped in the modified lithotomy position. The operation 
starts with a midline incision between the umbilicus and the pubic bone. If it appears from 
a first exploration of the abdominal cavity and bimanual palpation of the tumour that the 
process is resectable, the incision is prolonged above the umbilicus. The Trendelenburg 
position will allow to remove the small bowel from the abdominal cavity and provides a 
wide access to the pelvic cavity. The sigmoid colon is mobilised from the retroperitoneum 
and the left ureter is identified. The inferior mesenteric vessels are identified and transected 
distal to the origin of the left colic artery. The colonic mesentery is now transected in the 
direction of the origin of the sigmoid colon and the arterial arcade is transected. Umbilical 
tape is tied around the colon on both sides of the planned transection. The lumen of the 
quarantained colonic segment is injected with 100/o PVP iodine for bactericidal and 
cytotoxic purposes and the colon is subsequently transected using a linear stapler or by 
means of the Coop-Martell clamp.24 
A clamp is transversely put on the distal end of the transected colon and the sigmoid colon 
is stretched in vertical direction. A Kelly clamp on the distal stump of the inferior 
mesenteric vessels keeps the mesentery of the rectosigmoid colon stretched thus presenting 
the anatomical plane in front of the sympathic trunk for sharp downward dissection. The 
presacral space is easily reached. The pelvic peritoneum is opened on both sides towards the 
bladder or the cardinal ligaments of the uterus. Using sharp dissection in the avascular 
plane in front of Walldeyers fascia, the rectum is now freed out of the presacral hollow. At 
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the level of the third sacral vertebra Walldeyers fascia reflects towards the rectum and is 
transected. The dissection can be continued beyond this point by using decapitation scissors 
to pull the rectum towards the pubic bone till the anterior aspect of the coccyx is reached 
in combination with sharp dissection with long scissors. 
In female patients it is advisable to put a stitch through the uterine wall to apply traction. 
The pelvic peritoneum in front of the rectum should be opened 2 cm above and anterior 
to the deepest point of the cul de sac. Traction on the uterus presents the avascular 
rectovaginal septum for downward dissection. 
In the male patient the pelvic peritoneum in front of the rectum is incised in transverse 
fashion 2 cm above and anterior to the cul de sac while applying traction on the posterior 
aspect of the bladder. Sharp dissection behind the bladder will expose the seminal vesicles 
in front of Denonvilliers' fascia. Cephalad traction on the specimen eases sharp dissection 
in front of this fascia and behind the seminal vesicles. 
In both male and female the anterior and posterior aspect of the specimen are freed from 
the surrounding soft tissues. By pulling the specimen to the contralateral side the lateral 
stalks of the rectum can be stretched and should be transected close to the pelvic sidewall. 
The cranial and circumferential margins of the specimen are the same whether a 
rectos1gmoid resection or an abdominoperineal dissection is performed. The specimen can 
be compared with a cylinder with a length varying towards the anus. In the case of an 
abdominoperineal resection the lower end of the cylinder contains the levator muscles, the 
anal sphincter and the peri-anal skin. 
In a rectosigmoid resection the distal resection margin should be 2 to 3 cm below the 
macroscopic lower edge of the rectal cancer as measured in the fresh specimen. If the 
tumour is undifferentiated this distal margin should be 5 cm in order to encompass 
eventual distal intramural spread. The rectal mesentery is transected at the level of the 
planned resection margin or distal to it. As soon as a selection is made about the 
appropriate level of rectal transection the surgeon has to decide whether he will make a 
colorectal anastomosis or will close the rectal stump as in a Hartmann procedure.25 If the 
distal margin of the rectosigmoid resection is free of disease additional excision of the rectal 
stump will not add to the radicality of the procedure but may increase the risk of 
morbidity. Hence there is no need to remove the remaining rectal stump if it is too short 
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to preserve anal continence. 
Several sphincter saving procedures have been described during the past decades:the 
abdomino-anal pull through (Turnbull and Cutait), the colo-anal anastomosis (Parks) and 
the abdominotranscoccygeal resection (Localio). Interest in these techniques considerably 
diminished with the advent of circular staplers allowing to make very low colorectal 
anastomoses especially when the double-stapling technique is used. 
2.2.2 Technique of the hand-made colorectal anastomosis 
The rectal lumen is filled with PVP iodine for cytotoxic purposes. The rectum is clamped 
or obliterated with umbilical tape below the level of the tumour and seromuscular stay 
sutures are put in the rectal wall below the planned resection margin. The rectum now is 
transected and stay sutures are put through the full thickness of the margin of the rectum 
to replace the first three stay sutures. 
The proximal colon is adequately mobilised to reach the rectal stump while lying loosely 
in the presacral space. This often can only be achieved by taking down the splenic flexure 
of the colon. Sometimes the inferior mesenteric vein has to be ligated a second time below 
the pancreas to provide adequate mobility to the mesentery. 
The proximal colon now is prepared for the anastomosis by trimming the distal segment 
to remove the stapled end of the bowel crushed by the Coop-Martell clamp. Three stay 
sutures are put in place through the full thickness of the bowel wall. The anastomosis is 
started on the posterior aspect by putting vertical mattress sutures between the descending 
colon and the rectum. Throughout the years 3 / 0 chromic catgut has been used for the 
anastomosis. The sutures are put in sequence in the "Zeebedee" device, a spring-loaded 
suture-holding clamp.26 As soon as sutures have been put over 2 I 3 of the circumference the 
'"'Zeebedee" device is lifted to stretch the sutures and the descending colon is railroaded 
down towards the rectum. Sutures can now be tied starting in the middle. The anterior 
aspect of the anastomosis is closed with inverting stitches. If available the left part of the 
omentum is pedicled on the left gastro-epiploic artery and wrapped around the anastomosis 
or fixed on its anterior aspect. 
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2.2.3 Abdominoperineal resection 
The abdominal phase of the procedure is the same as for the resection of the rectosigmoid 
colon. 
In female patients dissection in the rectovaginal septum is continued downward till the 
upper level of the anal sphincter where the pre-existing anatomical plane stops. However, 
in female patients with a low rectal cancer it is advisable not to dissect in the rectovaginal 
septum but to open the posterior fornix and remove the posterior vaginal wall en bloc with 
the rectum in order to improve radicality.27 
In the male patients dissection in front of Denonvilliers' fascia continues beyond the upper 
part of the prostatic gland. 
On the dorsal aspect of the rectum dissection continues beyond the tip of the coccygeal 
bone. After transection of the last remnants of its lateral ligaments the rectum 1s 
circumferentially freed from the surrounding tissues down to the level of the levators. 
The perinea! phase of the operation starts with a purse string suture around the anus. An 
oval shaped incision is made around the anus. When the posterior vaginal wall is excised 
this peri-anal skin incision has a horse-shoe configuration. Deepening the incision into the 
subcutaneous fat the inferior haemorrhoidal vessels are transected. The St Marks perinea! 
retractor is positioned to spread the edges of the incision while keeping the specimen in the 
middle. On the dorsal aspect dissection is continued towards the anterior aspect of the 
coccyx and the presacral space is reached after transection of the anococcygeal ligament. 
The levators are cut on both sides of the coccyx. Introduction of the index finger next to 
the coccyx allows pulling down the levators for transection close to the bony pelvis. The St 
Marks perinea! retractor can now be put in a deeper position to spread the subcutis and the 
remnants of the levator muscle. Longitudinal incision on both sides of the posterior vaginal 
wall and transection of the vaginal attachments frees the specimen in the female patients. 
In the male patients anterior dissection progresses after identification of the transverse 
perinea! muscle. Dissection behind this muscle leads to the posterior aspect of the prostate. 
Difficulties in the anterior dissection in male patients can be avoided by exteriorizing the 
proximal end of the specimen via the presacral space. Downward traction on the specimen 
makes it easier to identify the correct anatomical plane on the posterior aspect of the 
prostate and remove the specimen. 
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After control of haemostasis the perinea! wound is closed with interrupted sutures of dexon 
on the subcutaneous fat and mersilene on the skin. Closure of the defect of the posterior 
vaginal wall is not needed. The pelvic peritoneum should be left open and, when available, 
a pedicled omental flap is pulled down to fill the presacral space. Sumpdrains are left in the 
pelvis for suction during 24 to 48 hours. 
3. LOCAL RECURRENCE AFTER "CURATIVE" LOCOREGIONAL 
RESECTION FOR RECTAL CANCER 
About 500/o of the patients dying from recurrent disease after curative surgery for rectal 
cancer have clinical evidence of pelvic recurrence alone or in combination with distant 
metastases. In postmortem studies the incidence of local recurrence is even higher.28 These 
local recurrences rarely are curable and moreover are often difficult to treat palliatively. 
Most of the patients with recurrent disease in the pelvis will face the ordeal of pelvic death 
unless they are "fortunate" to develop distant metastases leading to death before life with 
residual pelvic tumour becomes unbearable. 
A valid definition of local recurrence is any new tumour activity arising below the level of 
the innominate line and the promontory. Recurrent tumour at the level of the obturator 
fossa, the iliac vessels, the presacral space, the vagina or uterus, seminal vesicles, prostate 
and perinea! wound can be labelled as local recurrences. The origin of pelvic recurrences 
and the ways to avoid them will be shortly discussed in the following paragraphs. 
3.1 Local recurrence due to macroscopically inadequate resection 
If macroscopic residual tumour is left in the pelvis after the rectal resection it obviously 
means that the procedure was appallingly inadequate. Either the surgeon was not aware of 
infiltration into unresectable structures or fixation to resectable structures did not lead to 
their en bloc resection. Both mishaps can be avoided by always performing the operation 
with the patient in the modified lithotomy position thus allowing bimanual palpation and 
adequate assessment of the mobility of the tumour. Correct assessment by rectal 
examination alone is often impossible. Bimanual palpation with one hand in the pelvis and 
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the index of the other hand in the anus allows detection of fixation before progression of 
the operation beyond the point of no return.29 Heald mentions the "trial operation" in this 
respect. 30 This laparotomy and bimanual palpation may lead to three conclusions: radically 
resectable, definitely unresectable or eventually radically resectable in the future after high­
dose pre-operative radiotherapy.29 
3.2 Local recurrence due to lack of microscopic radicality 
This problem can be due to technical insufficiency during the procedure or to under­
estimation of the microscopical spread of the tumour. 
3.2.1 Short distal margin 
For the resection of differentiated rectal cancers a distal margin of 2 to 3 cm, as measured 
in the fresh specimen, should be adequate.3•3 1  For undifferentiated tumours a margin of 4 
to 5 cm is required. The mesorectum should be transected at least at the same level as the 
rectum. In sphincter preserving operations Heald advocates the excision of the entire 
mesorectum in order to avoid leaving microscopical disease in the mesentery of the 
remaining rectal stump.32 With the sphincter preservation in mind, the surgeon may have 
the tendency to "cone" towards the rectum while progressing with his downward dissections 
thus removing an inadequate amount of mesorectum and perirectal fat and eventually 
jeopardizing the radicality of the procedure.33 
3.2.2 Insufficient lateral margin 
During the routine pathologic examination of the specimen one slice is made from the 
lateral margins. A group from Leeds elaborately investigated the lateral margins of specimen 
and correlated the result with the clinical outcome. 10 The specimen of 52 patients were 
examined in two ways. Routine pathologic investigation disclosed tumour in the lateral 
margin in six of the 52 specimen (120/o). Elaborate examination of the same specimen 
revealed lack of radicality in the lateral margin in 14 or 270/o of these specimen and a local 
recurrence subsequently developed in 850/o of these 14 patients. It is evident that routine 
pathologic examination of a specimen yields incomplete information about the resection 
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margins and may confront the surgeon with a totally unexpected local recurrence due to 
lack of microscopic radicality in the resection margins. 
3.2.3 Retrograde carcinomatous lymphangitis 
Massive metastatic invasion of the nodes in the mesentery can obstruct the lymphatic flow 
and divert it in caudal and lateral direction. Unsuspected retrograde spread can be 
responsible for lack of microscopic radicality at the distal margin of resection of rectum 
and / or mesentery. 3•9•10 Healds philosophy of total mesorectal excision is based on this 
eventuality.32 While contemplating a sphincterpreserving operation in patients with an 
undifferentiated or mucinous adenocarcinoma this retrograde lymphatic spread is a serious 
hazard that should be taken into consideration, since these tumours metastasise to the 
nodes at an early stage. 
3.2.4 Residual nodal metastases 
Removal of the entire sigmoid mesentery is a requirement for adequate surgery for rectal 
cancer. The inferior mesenteric vessels should be transected distal to the origin of the left 
colic artery. Some authors advocate high ligation at the origin of the inferior mesenteric 
artery.ii.ls It is unlikely, however, that excision of a positive node at the level of the aorta 
will contribute to the cure of the patient. 
Positive nodes in the pelvic sidewalls or along the hypogastric artery are left behind after 
conventional resections. Pelvic lymphadenectomy en bloc with rectal resection has been 
advocated.36 However, it appears from the data from Memorial Sloan Kettering in New 
York37 and from St Marks in London38 that the additional morbidity caused by pelvic 
lymphadenectomy outweighs the theoretical advantage. 
3.2.5. Infiltration into neighbouring structures 
Adhesions between a rectal cancer and its vicinity are inflammatory in half of the cases and 
are due to malignant invasion in the other half.39 When in doubt, adhering structures or 
part of them, should be resected en bloc with the rectum to avoid leaving microscopical 
disease in the pelvic cavity.40 There is no place for hesitation into resecting seminal vesicles, 
a ureteric segment, part of the bladder, the uterus and / or the posterior vaginal wall. In the 
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male total exenteration should seriously be considered when the radicality is at stake. 
4 PEROPERATIVE IMPLANTATION OF MALIGNANT CELLS 
The hazard of implantation of viable exfoliated tumour cells in the anastomosis or in the 
pelvic cavity has been described long ago and irrigations of the rectal lumen with 
mercurychloride and alcohol have been propagated. Umpleby recently showed the presence 
of viable and transplantable exfoliated tumour cells in the lumen at a distance from a 
colonic cancer.41 These cells cannot implant on intact mucosa but a freshly made colonic 
anastomosis, an haemorrhoidectomy scar or the deperitonealised pelvic sidewalls are a good 
environment for implantation and growth of these exfoliated cancer cells.42-44 
Spill of tumour cells can be considerably decreased by adequate surgical technique and 
appropriate precautions. Sharp dissection not only helps to stay in the right anatomical 
plane but avoids opening tissue planes invaded by microscopic tumour infiltration. Blunt 
dissection on the other hand disrupts anatomical planes and tears lymphatics that may shed 
tumour cells in the pelvic cavity . .)() Leaving the appropriate anatomical plane or undue 
traction during blunt dissection may result in accidentally opening the bowel in the vicinity 
of the tumour with the inevitable consequence of tumour spill. After accidental perforation 
of the specimen during an abdommoperineal dissection the risk of pelvic recurrence is 
40%.45.46 The disastrous effects of peroperative tumour implantation can be avoided by the 
liberal use of PVP iodine in the lumen of the bowel.47 
5 PERI-OPERATIVE RADIOTHERAPY 
High pelvic recurrence rates remain a major problem despite efforts to carry out adequate 
resections for rectal cancer. Although increased survival rate is the ultimate purpose of our 
efforts, we have to accept that a percentage of our patients will die from disseminated 
cancer, even after so-called curative resection. Our major goal should be to avoid pelvic 
disease, whether isolated or as component of recurrent tumour, in order to offer our 
patients a comfortable and dignified existence without the grim prospect of pelvic death. 
Detailed histological studies of surgical specimens show that these pelvic recurrences are 
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caused by microscopic residual cancer in the surgical margins or in unresected lateral pelvic 
wall nodes. 10 For the past 40 years radiotherapy, a logical option, has been utilized as a 
complement to radical surgery. Initial studies investigated the effect of pre-operative 
radiotherapy (20 Gy in 2 weeks) and failed to show an effect on the survival.48'49 
In the Veterans Administration study a subgroup of patients with a rectal cancer seated 
within 8 cm from the anus received an additional dose (5 Gy in 2 weeks) via a perinea! 
field. After subsequent abdominoperineal resection this subgroup showed a significantly 
improved survival when compared to the control group (41 versus 28%). A similar trial of 
pre-operative radiotherapy (34.5 Gy in 3 weeks) was carried out by the EORTC.55 This 
radiotherapy course did not affect the 5-year survival, however, there was a significant 
difference in pelvic recurrence rates. 
Selection of the patients who are at risk for a local recurrence and thus may benefit from 
pre-operative radiotherapy is a problem. Pre-operative radiotherapy is attractive since the 
periphery of the tumour probably has better oxygenation prior to resection and there is less 
likelihood that adhesions will trap small bowel in the pelvis during the treatment. 
Postoperative radiotherapy, aimed at elimination of residual microscopic disease, has been 
widely used because surgery is not delayed and favourable cases (Dukes' A), less at risk for 
local recurrence, can be excluded. The hazard of radiation damage to small bowel loops 
adherent in the pelvis is a serious drawback. Although non-randomized data suggest a 
benefit with postoperative radiotherapy in reducing local recurrence, the randomized data 
from the Gastrointestinal Study Group51 and the National Surgical Adjuvant Breast / Bowel 
Project52 do not support this conclusion. The debate about the choice between post- and 
pre-operative radiotherapy is not entirely settled. The available literature was recently 
analysed and allowed to conclude that peri-operative adjuvant radiation therapy is beneficial 
for patients with deeply invasive or node positive carcinoma of the rectum and that doses 
of at least 30 Gy should be used.53 We strongly favour pre-operative radiotherapy.z9 
Familiarity with and trust in new technology such as endosonography may allow to select 
patients at risk for local recurrence as candidates for pre-operative radiotherapy. 
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6 PERI-OPERATIVE CHEMOTHERAPY 
As a considerable percentage of patients is succumbing to distant metastases following 
potentially curative resection for rectal cancer, the concept of adjuvant chemotherapy is the 
logical consequence. 5-Fluorouracil, the most commonly used agent in treating 
gastrointestinal cancer fails to significantly alter the survival of patients with colorectal 
cancer.s4.ss In a study conducted by the Gastrointestinal Tumour Study Group Fluorouracil 
and Semustine (methyl CCNU) were combined in a four arm study. This study showed that 
the combination of postoperative radiotherapy and the above mentioned chemotherapeutic 
regimen had a beneficial effect on both the local recurrence rate and the survival. This 
effect was less obvious in the arms with postoperative chemotherapy alone or postoperative 
radiotherapy alone when compared to surgery alone.52 A subsequent study comparing 
postoperative radiotherapy with the combination of postoperative chemotherapy 
(Fluorouracil and methyl CCNU) and postoperative radiotherapy confirmed the beneficial 
effect of the combined modality treatment on both the local recurrence rate and the 
survival.56 Taking the leukaemogenic potential of CCNU into consideration, the 
combination of Fluorouracil, Leucovorin and eventually interferon may be a suitable 
alternative. 
In a recent publication radiotherapy and chemotherapy (Fluorouracil and Leucovorin) were 
used prior to surgery in cases with unresectable rectal cancer.)6 The resectability and 
response rates were higher than those previously reported for pre-operative radiotherapy 
alone. These results inspire the use of Fluorouracil and Leucovorin as neo-adjuvant 
chemotherapy, prior to radiotherapy and surgery, to be followed with postoperative adjuvant 
courses with the same regimen. 
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ABSTRACT 
Advanced rectal cancer 
The authors report their experience with the staging laparotomy as a means of identifying 
and preparing patients for high-dose pre-operative radiotherapy. Twelve patients had 
clinically unresectable cancers of the rectum. The goal of the staging laparotomy is to assess 
mobility and tumour size by means of bimanual palpation, to stage the abdominal cavity, 
and to fashion an end colostomy at the level of the descending colon. Eight patients 
ultimately underwent radical resection. Three died during follow-up due to haematogenic 
metastases without recurrent pelvic disease. Five patients are alive with no evidence of 
disease and have been followed for an average of 34 (range, 20 - 64) months. 
Key words: Staging, rectal cancer, radiotherapy 
INTRODUCTION 
The academic hospital of the Groningen University is the referral center for advanced 
medical care for the three northern provinces of The Netherlands. The patients described 
in this article were treated between March 1980 and November 1984. During this period 75 
patients with rectal cancers were treated by one surgeon (RCJV). One third of these patients 
were referred from other hospitals, thus suggesting a negative selection of patient material. 
This article describes a treatment strategy designed for fixed or borderline resectable rectal 
cancers and put into practice on 12 patients. 
The main problem is that the exact clinical staging of advanced rectal cancer is not 
possible. For cancers below the peritoneal reflection, the depth of invasion and the 
infiltration in neighbouring structures can be assessed in a more or less accurate way'. 
However, for cancers seated at the level of the peritoneal reflection or higher, a sound 
judgement is even more difficult. The information provided by CT scan and intraluminal 
sonography is not yet reliable enough as far as discrete tumour infiltration in adjacent 
structures or the perirectal fat is concerned. High-dose pre-operative radiotherapy can be 
very inconvenient and dangerous to the patient having a stricturing rectal cancer. Therefore, 
the concept of staging laparotomy was introduced in patients where clinical suspicion of 
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unresectability is present. Unresectability means that although macroscopic radicality may 
be obtained, it can be anticipated that the pathologic report will not confirm this 
assumption. 
The goal of the staging laparotomy is threefold. The first goal is assessment of the 
resectability. The laparotomy is carried out with the patient in the modified lithotomy 
position, thus allowing for a thorough bimanual examination. The authors are convinced 
that this is the most reliable way to assess the mobility and resectability of a rectal cancer. 
It has been experienced that often tumours diagnosed as fixed by digital examination appear 
to be mobile during bimanual palpation and vice versa. The second purpose is proper 
staging of the abdominal cavity in regional and distant disease. Equivocal CT scans, 
endosonography, and sonography of the liver can be verified and histological proof of 
eventual hepatic metastases or peritoneal deposits can be obtained. The size and number of 
hepatic metastases give an idea of the life expectancy and the treatment strategy can be 
changed accordingly. The pelvis can be inspected thoroughly for the presence of peritoneal 
metastases or extramesenteric metastatic nodes. The third reason for laparotomy is that an 
end colostomy on the descending colon can be constructed. The total faecal diversion thus 
created makes it easier for the patient to tolerate high-dose pre-operative radiotherapy and 
is especially beneficial to patients who require an additional perinea! field, since maceration 
of the peri-anal skin is avoided. 
PATIENTS AND METHODS 
After induction of anaesthesia, the rectum is flushed with saline and povidone-iodine 
(10%) is instilled as soon as the returning fluid is clear. An indwelling catheter is inserted 
into the bladder and the patient is draped in the modified lithotomy position. The 
procedure is started with a generous midline incision reaching above the umbilicus. First, 
the peritoneal cavity is explored thoroughly for distant metastases. Second, tumour size and 
mobility are assessed by bimanual examination with the index finger of the left hand in the 
anus and the right hand in the pelvis. The pelvic wall is palpated for detection of 
extramesenteric metastatic nodes. Primary resection is performed in cases where local 
radicality can be expected. If the staging laparotomy reveals that local radicality cannot be 
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anticipated from surgery alone, then the patient is a candidate for high-dose pre-operative 
radiotherapy. The left colon is mobilized from the retroperitoneum and transected at the 
level of the transition between the descending and sigmoid colon. An end colostomy is 
fashioned from the proximal colon. Redundant sigmoid colon is resected with a small 
wedge of the mesentery. The distal colon is closed either with staples and buried in the 
subcutis of the lower part of the incision as a hidden colostomy, or exteriorized as a 
mucous fistula. The pelvic peritoneum never is opened for the purpose of exploration since 
this may originate adhesions of small bowel loops in the pelvis and subsequently expose the 
patient to an increased hazard of radiation enteritis. 
Between March I 980 and November 1984, 68 patients with rectal carcinomas were treated 
surgically by one of the authors (RCJV). Seven patients had 10 x 3 Gy and two patients 50 
Gy pre-operative radiotherapy without staging laparotomy. The procedure described above 
was carried out in 12 patients (Table 1). 
Table 1. Motivation of the 12 staging laparotomies 
Considered locally incurable by means of primary surgery (n=4) 
Rectovaginal fistula (2) 
Invasion of vagina (1) 
Fixation to sacrum (1) 
Considered borderline resectable (n=4) 
Tumor size (1) 
Suspicion of fixation to seminal vesicles (3) 
Unduly considered as primarily resectable (n==4) 
Invasion of pelvic floor (2) 
Extramesenteric nodal metastases (1) 
Fixation to sacrum (1) 
There were six males and six females. The average age was 58 (range, 37-77) years. Four 
patients had a planned staging laparotomy because they were considered incurable by 
primary surgery. Two of these patients had rectovaginal fistulas caused by adenocarcinomas 
of the rectum and a third patient had a cloacogenic cancer invading the posterior vaginal 
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wall. The fourth patient had a rectal cancer fixed to the sacrum. 
Four tumours were considered unresectable on clinical grounds because of tumour size (1) 
or the suspicion of invasion of the seminal vesicles (3). Four patients were scheduled for 
primary resection but at laparotomy unexpectedly the tumour proved to be unresectable due 
to invasion of the pelvic floor (2), the presence of a metastatic node along the hypogastric 
artery (1), or fixation to the sacrum (1). 
RESULTS 
The outcome of this treatment strategy is summarized in Table 2. 




1 peritoneal implants + hepatic metastases 
t 
-> p,lliati,o radiotherapy 
1 1  high-dose pre-operative radiotherapy 
[ 
1 peritoneal implants 
+ hepatic metastases 
10 re-laparotomy 
1
1 incomplete resection 
1 unresectable 
8 curative resections 
The staging laparotomy revealed unsuspected hepatic metastasis and deposits on the pelvic 
peritoneum in one patient. A split colostomy was fashioned to bypass the rectal stenosis 
and palliative radiotherapy was given. In the eleven remaining patients, high-dose pre­
operative radiotherapy was administered. The treatment field was limited to the pelvis and 
centered around the primary tumour. The tumour dose was 50 or 56 Gy administered over 
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5 to 6 weeks. The radiotherapy course never had to be interrupted and patients tolerated the 
treatment fairly well. Three weeks following radiotherapy one patient was admitted with 
small bowel ileus. At laparotomy he proved to have developed hepatic metastasis and 
carcinomatous peritonitis, thus making resection of the primary tumour unwarranted. 
A scheduled re-laparotomy was carried out four weeks after the end of radiotherapy in the 
ten remaining patients. In one patient the tumour still was fixed to the sacrum and proved 
to remain unresectable notwithstanding the radiotherapy. In another patient the surgeon 
underestimated the fixation of the tumour and had to leave malignancy behind on the 
surface of the sacrum. In the eight remaining patients the tumour proved to be resectable 
by means of abdominoperineal resection (2), a modified Hartmann procedure (1), a 
posterior exenteration (4), or a posterior exenteration combined with unilateral pelvic 
lymphadenectomy (1). 
A serious haemorrhage in the pelvis the evening of the abdominoperineal resection required 
re-laparotomy and packing of the pelvis in one patient. After removal of the pack, recovery 
was uneventful. The postoperative period of the remaining patients was uneventful. 
Histological examination of the specimen confirmed the impression that the resection was 
radical in these eight patients. The pathologist could find no residual tumour in the 
specimen resected for cloacogenic cancer (1). For the rectal adenocarcinomas, the Dukes' 
classification was as follows: Dukes' A (4), Dukes' B (2), Dukes' C with extranodal disease 
(1). This single Dukes' C case was a lady with a rectovaginal fistula. An inguinal metastatic 
node required groin dissection once she recovered from the posterior exenteration. 
In the course of follow-up, three patients died from distant metastases 14, 22 and 25 
months after resection of the tumour. None of these patients had clinical evidence of local 
recurrence in the pelvis. For the remaining five patients the average follow-up is 34 (mean 
42; range, 20 - 64) months. Pelvic recurrence has not been seen to date. 
DISCUSSION 
Radical surgical procedures for cancer in the lower two-thirds of the rectum still result in 
a 25 to 70% pelvic recurrence rate in the presence of gross transmural primary tumour 
penetration and / or lymph node metastases.2•3 It is highly likely that these pelvic recurrences 
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are due to the presence of residual tumour left behind in the pelvic wall, the lymphatics, or 
lymphatic lymph nodes in spite of curative surgery. 
There is agreement in the literature that the radicality of the surgery for these particular 
rectal cancers will benefit from adding radiotherapy to the treatment strategy.4 Controversy 
between pre-operative and postoperative radiotherapy is still not settled. The main advantage 
of postoperative radiotherapy is that patient selection can be based on pathologic staging 
and patients at risk can be identified. A major drawback of the postoperative radiotherapy 
is the hazard of radiation enteritis of the small bowel. Therefore, pre-operative radiotherapy 
is advocated. During the investigated period high-dose pre-operative radiotherapy without 
previous laparotomy was administered to two patients, and surgery followed. In seven other 
patients with less advanced rectal cancers, medium-dose radiotherapy (10 x 3 Gy) was 
followed immediately by surgery. 
The staging laparotomy as described in this article allows the selection of patients who may 
benefit from high-dose pre-operative radiotherapy. Thorough exploration of the abdominal 
cavity followed by bimanual palpation in the modified lithotomy position are the 
cornerstones of this staging. The creation of a total faecal diversion by means of an end 
colostomy is an excellent way of conditioning the patient for maximum tolerance during 
the protracted radiotherapy course. 
The concept of staging laparotomy and subsequent radiotherapy is not new. In 1976, 
Stevens et al.5 reported a series of 97 unselected patients who had high-dose pre-operative 
radiotherapy. During the first year of this study all patients had initial abdominal 
exploration to assess the extent of the tumour and a colostomy for deviation of the faecal 
stream from the area of irradiation. 
Of the 12 patients undergoing staging laparotomy in this study, eight ultimately underwent 
curative resection. There was an obvious downstaging in the surgical specimen as seen in 
other series. 6 One patient proved to have a metastatic node along the left hypogastric artery 
during the staging laparotomy. After the high-dose pre-operative radiotherapy, posterior 
exenteration combined with pelvic lymphadenectomy on the affected side was carried out. 
Investigation of the specimen revealed that none of the pelvic or mesenteric nodes showed 
metastases and that the original tumour was staged as Dukes' A. This is an example of an 
incurable case, made potentially curable by means of high-dose pre-operative radiotherapy. 
28 Advanced rectal cancer 
The fact that three of the nine patients died from distant metastases during follow-up shows 
that the patients indeed had a compromised future. The absence of pelvic recurrence during 
follow-up, and the average disease-free survival of 34 months in the five remaining patients 
suggest the beneficial effect of pre-operative radiotherapy. 
It is much too soon to hope that this treatment policy will affect the 5-year survival in this 
group of patients with unresectable tumours. It can be stated, however, that the local 
radicality benefited from this strategy without causing mortality and with acceptable 
morbidity. It is highly likely that refinement of noninvasive staging methods will make 
staging laparotomy less mandatory in the future. The fashioning of an end colostomy, 
however, still will be beneficial in the majority of patients who require high-dose pre­
operative radiotherapy. 
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ABSTRACT 
Advanced rectal cancer 
The authors report their experience with 20 female patients with advanced rectal cancer in 
whom rectal excision was combined with concomitant excision of the uterus and / or 
posterior vaginal wall. Six patients presented with a malignant fistula between the rectum 
and the genital tract; ten had pre-operative radiotherapy, with a total dose of 50 Gy in seven 
patients and 30 Gy in three. 
The resection was judged as radical in 18 patients; the specimen was staged as a Dukes' B 
in eight and a Dukes' C in ten cases. Three patients died within the follow-up period, due 
to intercurrent disease, without evidence of recurrence. Seven patients have been followed 
without evidence of disease for an average of 91 (range, 39 - 143) months. One patient is 
alive 5 years after surgery with a pelvic recurrence. 
Seven patients succumbed to distant metastases alone (N "' 4) or to a combination of 
haematogenous metastases and pelvic recurrence (N : 3). 
The authors make a plea for local radicality in advanced rectal cancer in female patients, 
to preserve quality of life in most patients and provide cure in some. 
Keywords: Rectal cancer, posterior exenteration 
INTRODUCTION 
Local recurrence in the posterior vaginal wall is a common finding after abdominoperineal 
resection in female patients. 1 Confronted with rectal cancer showing frank invasion of the 
vagina or suspicion thereof, one should extend the rectal resection in the anterior plane by 
removing the uterus and / or posterior vaginal wall. 
The literature about rectal cancer from the last decades features topics such as sphincter­
saving procedures and peri-operative radiotherapy. Little attention has been paid to the 
subject of excision of the posterior vaginal wall or uterus. Reviewing the French literature 
we were astonished to find a vast amount of publications, some even 80-years-old, on this 
particular subject. z-4 
In their major reference book Patel and Leger5 give elaborate technical information about 
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this type of operation, but relatively little attention has been paid to this subject in the 
English literature. Goligher6 and Corman7 briefly mentioned excision of the posterior 
vaginal wall and hysterectomy. Enquist and Block8•9 published a study on lymphatic 
connections between the rectum and the female genital tract and gave an elaborate technical 
description of the posterior exenteration in a second article. Several papers report on 
incidental hysterectomy for malignant invasion of the womb by rectal cancer but the 
benefit of elective hysterectomy is rarely emphasized. 
PATIENTS 
Between 1 January 1978 and 31 December 1986, 62 female patients with primary 
adenocarcinoma of the rectum were seen by one of the authors (RCJV) in the Groningen 
University Hospital. Nine patients were inoperable and four had only palliative 
electrocoagulation. Forty-nine patients underwent resection, in 20 (400/o) of whom tumour 
invasion required excision of a part of the female genital tract en bloc with the rectum. The 
average age of the patients at surgery was 68 (mean 72; range, 39 - 86) years. Local tumour 
extension in these patients might have jeopardized local radicality after a conventional 
resection. The experience with these 20 patients will be reviewed. 
At presentation six patients had a rectovaginal fistula. This malignant perforation was 
localized in the cervix in one patient, in the posterior fornix in another and in the lower 
third of the rectum in four. In ten patients treatment started with pre-operative 
radiotherapy because of clinical suspicion of transmural tumour penetration. Three patients 
received a total tumour dose of 30 Gy in ten fractions with the purpose of increasing local 
radicality at subsequent surgery. In seven patients the tumour was considered inoperable or 
borderline operable and high-dose pre-operative radiotherapy (total tumour dose 50-56 Gy 
in 5 to 6 weeks) was administered. In five of the latter patients the high-dose pre-operative 
radiotherapy was preceded by staging laparotomy as described previously. 10 
The procedures are summarized in Table 1. Combined hysterectomy and resection of the 
posterior vaginal wall (hysterocolpectomy) was carried out in 12 patients. In eight patients 
only the posterior vaginal wall was removed because of previous hysterectomy (N = 2) or 
lack of indication for hysterectomy (N = 6). In one patient tumour growth required en bloc 
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Table 1. Surgical procedures 
uterus + PVW (12) 
Gynecological excision n = 20< 
PVW (8) 
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------ abdominoperineal resection (16) Rectal excision n = 20 -------- Hartmann procedure (4) 
resection of the lower part of the left ureter followed by reimplantation into a Boari-plasty. 
In another patient, with a low rectovaginal fistula, a metastatic inguinal node became 
obvious after high-dose pre-operative radiotherapy. A groin dissection was carried out 6 
weeks after the posterior exenteration. 
SURGICAL TECHNIQUE 
The patient is draped in the modified lithotomy position. After a generous midline incision 
the entire abdominal cavity is explored for distant metastases or other significant pathology, 
following which the primary tumour is identified and its mobility assessed. For a cancer 
seated at the level of the peritoneal reflection, bimanual palpation is mandatory to assess 
its mobility, invasion of adjacent structures, fixation to the pelvic sidewalls or nodal 
metastases in the mesorectum, and to plan the extent of the resection accordingly. 
If this bimanual palpation yields evidence of fixation or the possibility of primary surgery 
not achieving local radicality, the laparotomy is considered a staging procedure.10 When 
after thorough assessment of the tumour mobility the patient seems eligible for primary 
surgery, preparations are made for resection. After mobilization of the sigmoid colon and 
identification of the left ureter, the inferior mesenteric artery and vein are ligated and 
transected below the origin of the left colic artery. The mesocolon is incised at the level of 
the first sigmoidal artery and transection follows. The root of the mesocolon is freed from 
the anterior aspect of the aorta and the presacral space is reached. When posterior 
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exenteration is required the ovarian vessels are ligated and transected after identification of 
the right ureter. After this the round ligaments are ligated and the uterine arteries identified 
and divided. Sharp dissection is used to free the rectum out of the presacral space. 1 1  The 
lateral stalks of the rectum are identified and transected close to the pelvic wall, and 
subsequently the bladder is freed from the anterior vaginal wall and the anterior fornix is 
incised transversely. The cardinal ligaments are transected next and the dissection can now 
proceed towards the levator muscles. 
Figure I .  Posterior exenteration after high-dose pre-operative 
radiotherapy. Anterior aspect of the specimen; the arrow points 
to the rectovaginal fistula. 
The perinea! phase of the resection i� 
started with a pursestring closure of 
the anus, followed by a horse-shoe 
incision, open towards the vagina, 
made around the anus. After 
transection of the anococcygeal 
ligament the levator muscles are 
identified and transected. The lateral 
wall of the vagina is incised in an 
upward direction to reach the 
transverse incision in the anterior 
fornix made at an earlier stage. The 
surgical specimen can now be 
removed (Fig. 1). 
If there is no need to remove the 
uterus, the transverse incision in the 
vagina is made in the posterior 
fornix during the abdominal phase 
of the procedure. The transverse 
incision can be extended along the 
lateral walls of the vagina during this 
perinea! phase to allow for en bloc excision of the posterior vaginal wall and the rectum. 
No attempts are made to close the defect in the posterior vaginal wall, and in order to 
facilitate postoperative bladder drainage a suprapubic catheter is inserted. 
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No attempt is made to close the defect in the pelvic peritoneum. In an earlier part of our 
study sump drains were used to irrigate the presacral space for 24 hours after surgery, 12 but 
recently we used drains (Axiom) 1 for suction alone. The perinea! wound is closed in two 
layers, using PGA for subcutis and Mersilene for the skin (Fig. 2). 
Figure 2. The aspect of the vulva of the same patient 10 days 
all.er surgery. 
RESULTS 
Operative or postoperative mortality 
did not occur with these patients. 
One 72-year-old woman with chronic 
leukaemia developed pelvic sepsis 
after posterior exenteration with 
ureteric reimplantation. She recov­
ered after a hospital stay of three 
months. Another patient proved to 
have multiple metastases at the level 
of the pelvic floor and the iliac 
vessels. Postoperative adhesions 
required laparotomy to bypass the 
compromised small bowel loops and 
her hospital stay amounted to 41  
days. The postoperative course of  the 
18  other patients was uneventful and 
their average postoperative hospital 
stay was 17 (range, 12  - 32) days. In 
all patients the posterior wound 
healed primarily. One patient developed a perinea! hernia, requiring reconstruction, two 
years after the resection; the remaining patients had no vaginal or perinea! discomfort 
during follow-up. 
Manufactured by Axiom Medical Inc., 7625 E Rosecrans. Paramount, California 90723, U.S.A. 
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Table 2. Dukes' classification of the 20 cases 
Dukes' A 0 
Dukes' B 9* 
Dukes' C 10# 
Dukes' D 1 
* One patient had a metastatic node on the hypogastric artery. 
# One patient had nodal metastases on the iliac vessels and another had 
groin metastases at surgery 
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In Table 2 the pathological classification is given. The tumour was staged as Dukes' C in 
ten patients, in two of whom histologic proof of extramesenteric nodal metastases was 
obtained. In nine patients the cancer was classified as a Dukes' B, in one of whom the 
staging laparotomy revealed a positive node on the left hypogastric artery. Subsequent high­
dose pre-operative radiotherapy was followed by a posterior exenteration combined with a 
left-sided pelvic lymphadenectomy. Pathologic investigation of this specimen revealed no 
remaining nodal metastases, although the tumour was initially present in an extra­
mesenteric node as histology showed during staging laparotomy. None of the patients had 
a Dukes' A tumour. Histologic proof of malignant invasion of concomitantly excised 
viscera was found in all six patients presenting with a fistula and in the one patient with 
a compromised ureter. The absence of histologic proof of malignant invasion in the excised 
viscera of the other patients does not make these excisions meaningless, since all adhesions 
should be considered as malignant until proven otherwise. 
One patient presented with retrograde carcinomatous lymphangitis m the rectovaginal 
septum. Laparotomy after high-dose radiotherapy disclosed hepatic metastases, but 
nevertheless, a palliative abdominoperineal resection with excision of the posterior vaginal 
wall was carried out. No pelvic recurrence was detected before she died 21 months later. 
Among these 20 patients the extended surgery may be labelled as palliative in two cases: the 
one with hepatic metastases and the other with residual metastatic nodes in the pelvis. 
Surgery in the remaining 18 patients was potentially for cure and the outcome is 
summarized in Table 3. 
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Table 3. Follow-up to 30 November 1989 of the 18 patients with potentially 
curative resection. 
lntercurrent death, NED 
Died with haematogenic metastases only 
Died with distant metastases and pelvic recurrence 
Alive with pelvic recurrence 
In follow-up, NED 
3 (at 13, 41 and 59 months) 
4 (at 9, 9, 23 and 59 months) 
3 (at 12, 30 and 44 months) 
59 months 
7 median 66; range, 39-143 months 
(average length of follow-up 91 
months) 
Three patients died in the follow-up period without evidence of disease. One woman 
succumbed to a heart attack 59 months after surgery. The patient with chronic lymphatic 
leukaemia succumbed 13 months after surgery as a sequela of a chronic urinary tract 
infection. The third patient died at the age of 83 of unspecified medical problems 41  
months after surgery, but certainly without evidence of tumour. 
Death was caused by new tumour activity in seven patients. Four patients died of 
haematogenic metastases after a follow-up of 9, 9, 23 and 59 months, without any evidence 
of local failure. Three patients developed pelvic recurrence and concomitant distant 
metastases and died 12, 30 and 44 months respectively after the operation. The patient who 
underwent a groin dissection subsequent to the posterior exenteration proved to have a 
recurrence in the pelvic side walls 4 years after the resection and is alive after a follow-up 
of 59 months. 
Up to 30 November 1989 seven patients were still in follow-up without evidence of disease 
for an average of 91 (range, 39 - 143) months. Their mean survival is 6.5 years. Two of 
these eight patients presented initially with a fistula to the genital tract, and four of these 
surviving patients had a Dukes' C stage, and three a Dukes' B stage. 
DISCUSSION 
The treatment strategy of rectal cancer should minimize the hazard of local recurrence. 
Residual disease resulting from incomplete excision, and the subsequent ordeal of pelvic 
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recurrence must be avoided at all costs. The controversy between pre-operative radiotherapy 
and adjuvant radiotherapy is still going on, and in many publications postoperative 
radiotherapy is advocated to decrease the rate of local recurrence. We are concerned about 
the hazard of radiation enteritis caused by radiotherapy subsequent to pelvic surgery and 
therefore do not share this enthusiasm. We strongly believe meticulous extensive resection 
is the cornerstone of pelvic radicality. When tumour extension requires radiotherapy to be 
included in the treatment strategy, we advocate the use of a pre-operative course based on 
clinical and / or surgical staging. 10 
Resectability and the choice of a particular treatment strategy are determined by several 
factors. The surgeon's decision is influenced by his / her experience and knowledge of 
tumour behaviour. Patient factors such as age, general condition and concomitant disease 
may seriously limit the choice, and urge a compromise between the best and the most 
feasible solution. These patient factors may limit the applicability of high-dose pre-operative 
radiotherapy, however, without limiting the extent of the surgery. Tumour factors such as 
local tumour growth and possible distant metastases are very important in the process of 
decision, but the presence of hepatic metastases should not be a reason to deny a patient 
the benefit of a locally radical resection because these palliative resections do have a 
beneficial effect on the quality of life without affecting the length of survival. 
In female patients, fortunately, the anatomy allows for an easy extension in the anterior 
direction, thus increasing the radicality of the procedure. Concomitant hysterectomy 
and / or excision of the posterior vaginal wall is justified for various reasons. Local 
recurrence after abdominoperineal resection is often found in the posterior vaginal wall as 
described by Gilbertsen.1 From a series published by Moossan it became obvious that the 
rate of local recurrence after excision of the rectum for a tumour invading the perirectal fat 
is as high as 400/o. Veazey and McBride14 reviewed charts of female patients who underwent 
an abdominoperineal resection. Among patients with previous or concomitant hysterectomy 
the pelvic recurrence rate was only 40/o, but 360/o in those whose uterus was left in situ. They 
concluded that this high pelvic recurrence rate in women may lend support to consideration 
of a posterior exenteration in all female patients with advanced carcinoma of the rectum. 
A number of sound, anatomical, oncological and practical reasons prevail for the anterior 
extension of the rectal resection. At the level of the rectovaginal septum, the anatomical 
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margin between perirectal fat and vaginal wall, is a thin layer of loose connective tissue, but 
in the vicinity of the anal sphincter there is no anatomical margin at all. 15 A wide 
anatomic excision of a low rectal cancer seated on the anterior wall with conservation of 
the vagina is therefore virtually impossible. Lymphatic connections between the rectum and 
the female genital tract, as demonstrated by Block and Enquist 16 and the fear of 
carcinomatous lymphangitis in the rectovaginal septum or the posterior fornix, are 
additional reasons to advocate at least concomitant excision of the posterior vaginal wall. 
It often happens that the surgeon faces adhesions between a bulky rectal tumour and the 
female genital tract. These adhesions should be considered as being malignant and dealt 
with accordingly. In this way, the chance of leaving residual tumour in the pelvis is 
minimized. 
The ordeal of bladder prolapse through the posterior wound and permanent voiding prob­
lems after abdominoperineal resection combined with hysterocolpectomy as described by 
Leibovici 17 was never seen by us. Two factors might explain why this major complication 
was not observed. One is the routinely insertion of a suprapubic catheter for bladder 
drainage. Micturition training by occlusion of the suprapubic catheter was started about a 
week after surgery, and as soon as the bladder residual was less than 100 ml, the catheter 
was removed, and micturition usually remained normal. The second explanation for the 
absence of permanent voiding problems is that closure of the pelvic peritoneum was not 
attempted. The small bowel obliterating the presacral space may have avoided posterior 
displacement of the bladder. 
The low pelvic recurrence rate obtained in this series of advanced rectal cancers can be 
attributed in the first place to the extent of the surgical resection. There is no doubt that 
pre-operative radiotherapy has been contributing to the local radicality in some cases. Our 
experience with these 20 female patients shows that rectal resection with en bloc resection 
of uterus and / or posterior vaginal wall can be carried out without mortality and with an 
acceptable morbidity and offers a chance of cure. The resulting mutilation is acceptable as 
a price for local radicality. We should bear in mind that in female patients with advanced 
rectal cancer a more minor operation exposes the patient to the ordeal of a local recurrence 
that will undoubtedly interfere with sexual function and will lead to a difficult death in the 
majority of them. 
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ABSTRACT 
Advanced rectal cancer 
The authors describe their experience with the extended Hartmann procedure as the elective 
and definitive operation in a selected group of 36 patients having primary adenocarcinoma 
of the rectum. The operations were carried out between I January I 978 and 3 I December 
1989. The average age of the patients was 70 (range, 37 - 84) years. Ten patients had pre­
operative radiotherapy because of deep infiltration and (or) fixation of the tumour. In this 
series the Hartmann procedure was chosen because abdomino-perineal excision was not 
needed and low anterior resection could not warrant acceptable continence. With a 
Hartmann procedure the risks of a low colorectal or colo-anal anastomosis were avoided 
while the perinea! excision was abandoned. Eight patients had hepatic metastases. The 
Dukes' classification of the remaining patients was A in two, B in nine and C in 17  
patients. Postoperative morbidity was within acceptable limits for this particular patient 
group. There was no hospital mortality. Twenty patients had a potentially curative resection 
prior to 31  December 1987, thus making them available for follow-up of at least 2 years. 
Ten of these patients have been in follow-up without evidence of disease for an average of 
76 (mean 65; range, 28 - 123) months. The authors conclude that the procedure is save and 
that the remaining rectal stump does not generate morbidity or discomfort. Considering the 
fact that only two of the 36 patients had a Dukes' A tumour, the low recurrence rate shows 
that the Hartmann procedure yields satisfactory pelvic radicality. 
Keywords: Rectal cancer, Hartmann procedure 
INTRODUCTION 
An exciting development in the surgery for rectal cancer has been the introduction of 
circular staplers. In the SOs, colorectal anastomoses were hand-made and a rectal stump with 
a length of 2 to 3 inches was considered as a requirement to achieve acceptable continence 
after anterior resection. Circular staplers allow for anastomoses to be made much closer to 
the dentate line. These very low anterior resections can be oncologically sound and varying 
rates of local recurrence are found in the literature. 1•3 Assuming that abdomino-perineal 
-- -- ------------
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resection and low anterior resection warrant the same oncological results, the permanent 
colostomy is the major difference. The type of operation, be it abdomino-perineal excision 
or anterior resection, should have no influence on the incidence of local recurrence as long 
as a sufficient margin of safety is achieved during rectosigmoid resection. 1·5 Goligher duly 
states that "it is a very pleasant bonus to avoid a permanent colostomy provided that the 
avoidance of the colostomy does not increase the operative mortality, lessen the prospect 
of ultimate cure, or leave the patient with grossly impaired anorectal function tantamount 
to having a perinea! colostomy".6 
In some patients, especially the elderly, the rectal cancer is not close enough to the anus to 
make an abdomino-perineal resection mandatory, but is too close to warrant acceptable 
continence after colorectal or colo-anal anastomosis. For these patients we have used the 
Hartmann procedure, a rectosigmoid resection with permanent colostomy. 
Hartmann presented this operation for the first time in 1921 during the 30'h convention of 
the French Surgical Society. 7 The operation consisted of a rectosigmoid resection carried out 
via a laparotomy. The distal rectum was closed and covered by closing the pelvic 
peritoneum, and an end colostomy was fashioned from the proximal end of the divided 
colon. This operation was a safe solution in a period when the recently introduced 
abdomino-perineal resection carried a high morbidity and mortality rate. For Hartmann 
this operation was definitive and in his monograph about rectal cancer he states: "I never 
even contemplated subsequent colorectal anastomosis since this should have jeopardized the 
safety of the initial operation". 8 With a Hartmann procedure the risk of a low anastomosis 
is avoided, while the perinea! excision is abandoned. 
During the past decades the Hartmann procedure has been advocated in emergencies caused 
by cancers or inflammatory conditions of the distal colon, frequently followed by 
restoration of the continuity of the colon.9•12 As an elective procedure for some patients 
with rectal cancer the Hartmann operation is rarely advocated. 13"15 At the Groningen 
University Hospital the Hartmann procedure has been carried out on an elective basis in 
a selected group of patients with adenocarcinoma of the lower rectum. This article reports 
our experience and discusses the hazards and benefits of the procedure. 
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PATIENTS 
Between 1 January 1978 and 31 December 1989, an elective and definitive Hartmann 
procedure was carried out in 36 patients with primary adenocarcinoma of the rectum. All 
the tumours were seated within 15 cm from the anal verge. There were 18 men and 18 
women. The average age was 70 with a range between 37 and 84 years. Ten of these 36 
patients were given pre-operative radiotherapy because of deep infiltration and (or) fixity of 
the tumour: high-dose (50 - 56 Gy) in seven and medium dose (10 x 3 Gy) in three patients. 
The administration of high-dose pre-operative radiotherapy for locally advanced cancers was 
based on the findings of a staging laparotomy, as described in a previous paper. 1 6  
No imaging techniques, such as CT or endosonography were used for the staging of the 
primary tumour. 
THE REASONS FOR USING A HARTMANN PROCEDURE 
In the majority of cases there was more than one reason for choosing a rectosigmoid 
resection without an anastomosis. In the entire group of 36 patients six were younger than 
60 years of age. In this subgroup the main indication for the Hartmann procedure was the 
doubt about pelvic radicality (N = 2), the presence of hepatic metastases (N = 1), the short 
rectal stump in combination with high-dose pre-operative radiotherapy (N = 2) or the poor 
quality of the pelvic floor (N - 1). For every individual patient the most important motive 
for this Hartmann procedure was scored (Table 1). 
Table 1. Mam reasons of using a Hartmann 
procedure. 
General condition 8 
Short rectal stump 1 1  
Hepatic metastases 8 
Lack of pelvic radicality 5 
Poor sphincter function 4 
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In eight patients this decision was based on the poor general condition as a combination 
of old age, severe diabetes, nutritional state or age-related ailments such as severe bronchitis, 
heart failure and arteriosclerosis. The average age of these eight patients was 78 (range, 69 -
84) years. It was thought that these patients would benefit most from the shortest possible 
procedure, avoiding the eventual morbidity of a perinea! excision or a low anastomosis. In 
1 1  patients, the rectal stump remaining after the resection was so short that anastomosis 
would have been difficult and hazardous and the rectal capacity in our opinion too small 
for an acceptable anorectal function. The median age of these patients was 71 (range, 37 -
81) years. Eight patients proved to have hepatic metastases and were considered to have such 
a short life expectancy that they would be best helped by a lesser operation providing 
adequate therapy for their severe rectal syndrome. In five patients, extensive transmural 
invasion by the rectal cancer (N � 3) and residual disease on the sacrum (N = 1) or the 
pelvic side walls (N ,.. 1) was the reason to anticipate local recurrence. A colorectal 
anastomosis was considered to be compromised early by recurrent pelvic disease. 
Four of the female patients had such a poor sphincter tone and weak pelvic floor that we 
thought they should have an end colostomy instead of an anus made incontinent by 
decreased functional capacity. 
TECHNIQUE 
Rectosigmoid resection is carried out with all the precautions to avoid tumour spill or 
tumour spread. A wide pelvic dissection is carried out in order to avoid compromising the 
oncological goal of the resection. An umbilical tape is tied around the colon above the 
tumour to avoid faecal spill during subsequent transection. A distal margin of 3 cm is 
considered sufficient and the lumen is flushed with PVP-iodine prior to transection. In 13 
patients the remaining rectal stump was so short that it  could either be closed from the 
perineum (N = 5) by putting some stitches through the anal canal or be left open (N = 8). 
In the remaining patients the rectal stump was closed from above with a linear stapler (N 
= 12) or with interrupted sutures (N � 11). 
The pelvic peritoneum was never closed. In the earlier part of this series a suction irrigation 
system was left in the presacral space. 17 Later, sumpdrains only were left in the presacral 
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space for about 24 hours. 
PATHOLOGY 
Eight patients had histologically proven hepatic metastases at laparotomy (Dukes' D). In the 
remaining 28 patients the rectal cancer was staged as a Dukes' A in two, Dukes' B in nine, 
and Dukes' C in 17. Residual macroscopic tumour was left after resection on the sacrum 
or the pelvic side-walls in two patients. Twenty-six of these 36 patients thus underwent a 
potentially curative resection. 
COMPLICATIONS 
There was no hospital mortality. One patient suddenly died at home several weeks after 
leaving the hospital. It is unclear whether death was caused by pulmonary embolism or 
myocardial infarction. The complications occurring in this series of patients are 
summarized in Table 2. The abdominal wound dehisced in two patients, 79 and 80 years 
old. One of these patients had liver metastases. The other patient recovered uneventfully 
and is still alive 1 1  years later. 
Table 2. Complications following Hartmann procedure 
Fatal embolism or myocardial infection 1 
Dehiscence abdominal wall 2 
Perinea! abcess 2 
Pelvic sepsis 
Pelvic haemorrhage and renal failure 
A presacral abscess developed in two patients. Adequate drainage was obtained by opening 
the rectal stump and the recovery was uneventful. 
Two patients had a prolonged hospital stay. A 72-year-old lady with chronic lymphatic 
leukaemia underwent an en bloc excision of the rectosigmoid, uterus, posterior vaginal wall 
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and distal ureter. The ureter was re-implanted into the bladder. Several weeks of intensive 
care treatment were needed to treat a septic condition of pelvic origin. The total hospital 
stay of this patient was almost 3 months. 
In a 68-year-old lady a life threatening haemorrhage from the presacral plexus required a re­
laparotomy. Haemodialysis, needed for the ensuing temporary renal failure, prolonged the 
hospital stay to 2 months. 
The uneventful recovery of most of the patients is apparent from the short postoperative 
hospital stay: 19  days on average, with a mean of 15 days and a range between 8 and 81 
days. 
FOLLOW-UP 
The follow-up status of these patients was last updated on 31 December 1989. 
The eight patients initially staged as Dukes' D all died, one of them developed a pelvic 
recurrence. Eight of the remaining 28 patients developed distant metastases during the 
follow-up and died. One of them had a pelvic recurrence. Distant metastases thus caused 
the death of 16 of 36 patients after an average follow-up of 15 (mean 10; range, I - 55) 
months. Three patients died of unrelated causes after 13, 34 and 2 months respectively. 
Three patients died with pelvic recurrence after 9, 12 and 26 months, apparently without 
distant metastases. In one patient residual disease had been left on the sacrum 
notwithstanding high-dose pre-operative radiotherapy. 
In one patient a local recurrence became evident in the vicinity of the rectal stump 6 
months after a Hartmann procedure for Dukes' C cancer. A retrospective study of the case 
suggests that this local recurrence originated from residual metastatic nodes in the 
mesentery of the rectal stump. An initial abdominoperineal resection might have avoided 
this local recurrence. High-dose radiotherapy was followed by a posterior exenteration. This 
patient is without evidence of disease 4.5 years after this salvage operation. 
Of the 36 patients, 14 (390/o) are in follow-up without evidence of disease. In 28 patients the 
Hartmann procedure was carried out prior to 31 December 1987, thus providing a follow­
up of at least 2 years. Of these 28 patients, ten (36%) have been in follow-up without 
evidence of disease for an average of 76 (mean 65; range, 28 - 123) months. The Dukes' 
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stage of these ten patients was A in two, B in four and C in four patients. The shortness 
of the rectal stump limited the production of mucus to the extent that it never generated 
discomfort. 
DISCUSSION 
The Hartmann operation was designed for cancers of the sigmoid colon and the upper 
rectum. Since Hartmann transected the rectum 3 cm distal to the tumour, the closure of the 
rectal stump was carried out in the immediate vicinity of the peritoneal reflection.7 
According to Goligher, the operation described in this article should be called an extended 
Hartmann procedure. 18 
It may sound out of tune to write about rectosigmoid resection with permanent colostomy 
while sphincter conservation is in surgical vogue. 
However, when confronted by a patient with rectal cancer, we should realize that there is 
a 500/o chance for the average case to reach the 5-year survival. Our first concern is to 
provide local radicality in the pelvis and to avoid local recurrence. Our second goal has to 
be eventual sphincter preservation. However, it appears that for some surgeons, preservation 
of the anus and avoidance of a colostomy are a requirement for quality of life and 
consequently are the first concern when confronted with a patient with rectal cancer. 
However, an end colostomy, decently made at the appropriate site of the abdominal wall, 
is not the curse it sometimes is considered to be. In fact, it is a lesser curse than anal 
incontinence caused by a decreased rectal capacity or poor sphincter function. 
There is agreement that a very low colorectal anastomosis allows good sphincter function 
but the decreased rectal capacity can drastically interfere with the social requirements for 
continence. Investigating the continence after low anterior resection McDonald and Heald 
found that 500/o of patients with an anastomosis within 5 cm from the anus were unable 
to delay visiting the toilet for more than 15 minutes. 19 These 15 minutes are a requirement 
to allow the patient to shop safely or to use public transport. Williams claims that virtually 
all the patients achieve continence for solid faeces after a very low anastomosis and that the 
deficiency in controlling flatus and liquid faeces is only temporary. This same author states 
that normal function is regained after a period of adaptation, varying from 6 to 18  
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months.20 
5 1  
In this series the eight patients presenting with distant metastases died around 12 months 
after the rectosigmoid resection. Eight other patients subsequently developed metastatic 
disease and died, on average, 17 months after the resection. These 16 patients died after a 
mean follow-up of IO (average 15; range, 1 - 55) months. Should these patients have had a 
low colorectal or colo-anal anastomoses, the majority would not yet have reached the end 
result of their continence when their general condition started deteriorating as a 
consequence of metastatic disease. 
In the Columbia Presbyterian series, pelvic infection was noted in 750/o of the extended 
Hartmann procedures. 14 The fact that this complication was only seen in three of 36 
patients in this series may be a result of the rectal stump being very short, the pelvic 
peritoneum being left open and drains left in the presacral space.22 
In 28 patients the Hartmann procedure has been carried out prior to 31  December 1987, 
thus making them available for a follow-up of at least 2 years. Of these patients, six 
initially had distant metastases, and residual tumour was left in the pelvis in two. 
Consequently 20 of these 28 patients had a potentially curative resection. Four patients 
succumbed to newly developed metastases and one patient had both pelvic and 
haematogenic metastases. Two patients died with local recurrence. Three patients died owing 
to unrelated causes with no evidence of disease. Ten of the 20 patients who had a 
potentially curative resection have been in follow-up without evidence of disease for an 
average of 76 (mean 65; range, 28 - 123) months, without discomfort of their short rectal 
stump. 
We conclude that the extended Hartmann procedure is a good alternative to abdomino­
perineal resection and low anterior resection, in patients where the former is not needed 
and the latter could not warrant acceptable continence. 
The experience shows that the procedure is safe and that the remaining rectal stump does 
not generate significant morbidity or discomfort. Taking into consideration that only two 
of the 36 patients had a Dukes' A tumour, the low local recurrence rate shows that the 
Hartmann procedure yields satisfactory pelvic radicality. 
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ABSTRACT 
We describe the results of clinical and (or) surgical staging used by the same surgeon to 
select a group of 41 patients with advanced rectal cancer for pre-operative radiotherapy. 
Fifteen patients with resectable but advanced rectal cancer were subjected to a short course 
of radiotherapy (30 Gy in 10 days), immediately followed by resection. High-dose pre­
operative radiotherapy (50-56 Gy in 5 weeks) was administered to 26 patients with 
borderline resectable or fixed cancer. Adequate resection of the tumour was possible in 21  
of these 26 patients 4 weeks after the end of the radiotherapy. A total of 36 patients thus 
underwent resection after pre-operative radiotherapy. 
No radiotherapy related acute or late morbidity was seen. On 3 1  December 1992 the results 
were investigated retrospectively. The median time since entering into the study was 87 
(range, 27 - 141) months. During the follow-up, pelvic recurrence was detected in six 
patients; one patient had concomitant distant metastases. The local recurrence free survival 
at 5 years calculated with the Kaplan Meier method was 720/o (950/o confidence interval 58-
85). Distant metastases without local recurrence developed in 1 1  patients. The calculated 
survival at 5 years was 450/o (950/o confidence interval 30.5-59). 
Keywords: Radicality, radiotherapy, rectal cancer, recurrence, staging 
INTRODUCTION 
Cancer of the colon and rectum has already become the third most common cause of death 
from malignant disease, following lung and breast cancer. With increasing life expectancy 
of the population we should expect to see the burden of this disease become heavier during 
the decades to come. 
The natural history of the disease has been described extensively and, despite technical 
improvements over the past decades leading to increased operability rate and decreased 
postoperative mortality, the survival rate has not improved and remains static at around 
500/o. 
In a large senes from Monash University describing the clinical outcome after 934 
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potentially curative resections, 332 patients died from recurrent disease; 510/o of these had 
clinical evidence of pelvic recurrence alone or in combination with distant metastases. 1 In 
another publication post-mortem evidence of local recurrence was even higher.2 
Pelvic recurrence is often seen after radical procedures for rectal cancers having gross 
transmural primary tumour penetration and / or lymph node metastases, and is due to the 
presence of microscopic residual disease left in the pelvic side walls, lymphatics or retained 
para-iliac nodes.3 Evidence of pelvic recurrence is the beginning of an ordeal for the vast 
majority of these patients. Our main concern should be the radical locoregional treatment, 
and the yardstick of the quality of the surgery should be the local recurrence rate. Peri­
operative radiotherapy seems to be the most promising adjunct to optimal surgery for the 
prevention of local relapse.4 The indication for postoperative radiotherapy is based on the 
pathological classification of the specimen, thus avoiding unnecessary treatment of patients 
with a Dukes' Stage A tumour. A first potential drawback of postoperative radiotherapy is 
delay of its administration caused by postoperative morbidity. The hazard of radiation 
enteritis is a second drawback. Despite the current NIH consensus statement5 favouring the 
use of postoperative irradiation, this modality remains controversial. In a four-arm 
randomized trial soon to be activated by the EOR TC, postoperative radiotherapy does not 
even feature. 6 A useful alternative could be the application of radiotherapy prior to surgery. 
As, in this situation, no guidance is available from pathological staging and not all the 
patients require adjunctive radiotherapy, patient selection must be based on imaging 
techniques, and clinical and eventually surgical criteria. 
PATIENTS AND METHODS 
During a IO-year period (I January 1981 - 31 December 1990) clinical and / or surgical 
staging were used by the same surgeon to select a group of 41 patients with advanced rectal 
cancer for pre-operative radiotherapy. The effect of the choice of treatment strategy on local 
recurrence and survival has been studied retrospectively. Two types of pre-operative 
radiotherapy were used, based on the findings from the staging procedure. A short course 
of radiotherapy (30 Gy in 10 days) was used to sterilise the periphery of advanced but 
resectable tumours. The purpose of the use of high-dose radiotherapy (50-56 Gy in 5 weeks) 
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for fixed or borderline resectable tumours was to increase the resectability rate. 
The staging of cancers in the lower half of the rectum was based on the combination of 
digital examination and rigid proctoscopy. Tumours in the upper half were staged at 
laparotomy (Fig. 1). 
Figure 1. Flow sheet of the clinical and eventual surgical staging and the resulting 
pre-operative radiotherapy. 
Pnmary resection 
Digital �10 x 3 Gy pre-operative radiotherapy ------> Resection (n = 15) 
and �50 - 56 Gy pre-operative radiotherapy -------> Resection (n = 2} 
proctoscopy "
'- � 
Primary resection (n = 17, no radiotherapy} 
Trial operation
� 
Inoperable (n = 9) 
Staging + colostomy -------> 50-56 Gy (n = 24} 
In cancers localized in the lower half of the rectum, these techniques allowed accurate 
assessment of the resectability of the tumour and selection of the type of pre-operative 
radiotherapy in most of the patients. If the tumour was considered resectable on digital 
examination, but was deeply invasive, as evidenced by palpable ulceration, or covered more 
than half of the circumference of the rectum, with transmural penetration of the cancer 
being suspected, patients were subjected to a short course of radiotherapy (30 Gy in 10 days) 
immediately followed by surgery (N = 15). If the tumour was definitely fixed to 
neighbouring structures to the extent that an attempt at primary resection was considered 
inappropriate, high-dose pre-operative radiotherapy was administered (50-56 Gy in 5 weeks), 
subsequently followed by an attempted resection (N = 2). 
In patients with a carcinoma in the upper half of the rectum, the tumour was too far away 
from the anus to allow accurate assessment of its mobility by digital examination, thus 
making it impossible to use clinical selection criteria for staging. In these patients, 
laparotomy was carried out as a "trial operation";7 with the patient in the modified 
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lithotomy position, bimanual recto-abdominal palpation allowed for accurate assessment 
of resectability. The trial operation was continued as a formal resection in 17 patients. If 
the circumferential infiltration into surrounding tissues compromised the radicality of 
primary surgery, a split colostomy was performed and the patient was scheduled for high­
dose pre-operative radiotherapy (N = 24). These patients with borderline resectable or fixed 
rectal cancers were scheduled for a new attempt at resection 4 weeks after the end of their 
pre-operative radiotherapy course. 
Radiation was delivered with supervoltage equipment. The borders of the anteroposterior 
(AP) / posteroanterior (PA) fields were 1 cm lateral to the widest bony margin of the true 
pelvis; the superior margin was 1.5 cm above the level of the sacral promontory; the 
inferior border was 1 cm below the inferior aspect of obturator foramina; the dorsal margin 
of the lateral portal was at least 1 cm behind the bony sacrum; and the ventral margin was 
2-3 cm anterior to the sacral promontory. Most of the patients with deeply invading 
tumours or with extension of more than half of the circumference were treated with 
AP I PA fields. A total of 30 Gy was given in ten daily fractions of 3 Gy delivered over 2 
weeks. If it was necessary to protect the small bowel, a four-field technique was used in this 
group. 
If there was doubt about resectability, patients were treated with a four-field technique, 
delivering 40 Gy in 20 fractions of 2 Gy per day, five fractions a week. This treatment was 
immediately followed by a boost of 5 to 7 fractions of 2 Gy, at five fractions a week, to the 
tumour area. The boost area was chosen according to the findings on rectal examination, 
operative and pathological data when available, and a barium enema during the simulation 
procedure. 
All patients who underwent a resection, either with curative or palliative intent, were 
included in the follow-up. Survival was measured from the moment of surgery and the time 
to local progression was from surgery until local relapse. Local relapse was defined as any 
tumour activity below the level of the innominate line and the sacral promontory, 
confirmed by imaging and / or histology, in patients with or without concomitant distant 
metastases. Survival curves and local relapse free survival curves were constructed according 
to the Kaplan-Meier method. Actual months of incidents were used for analyses. The results 
have been analysed to 31 December 1992. 
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The outcome of the treatment of the 4 1  patients subjected to pre-operative radiotherapy is 
summarized in Figure 2. 
Figure 2. Outcome of the treatment of 41 patients subjected to pre-operative radiotherapy 
Digita
/ 
10 x 3 Gy pre-operative radiotherapy (n=l5) -> 15 curative resections 
and 
� 
50 - 56 Gy pre-operative radiotherapy (n=2) -> 2 curative resections 
proctoscopy Trial operation (n•24) (staging and colostomy) -> 50-56 Gy pre-op. radiotherapy (n=24) 
[ 
Cerebral metastases (n= l) 
Carcinomatous peritonitis (n= l) 
Re-laparotomy (n=22) 
Inoperable (n=3) 
Resection (n= I 9) 
Palliative (n-3) 
Curative (n• 16) 
Fifteen patients with an advanced but resectable tumour in the lower rectum received a 
short course of radiotherapy (10 x 3 Gy} immediately followed by a potentially curative 
resection. Two patients received high-dose pre-operative radiotherapy (56 Gy in 5-6 weeks), 
followed 4 weeks later by attempted resection, resulting in potentially curative surgery in 
both. Among the patients with a proximal tumour, the trial operation obviated the 
necessity for pre-operative radiotherapy in 24, and an end-colostomy on the descending 
colon was fashioned. These patients all finished the course of radiotherapy of 50-56 Gy. A 
subsequent attempt to resect was cancelled in one patient because of cerebral metastases; 
another patient developed mechanical ileus, and carcinomatous peritonitis became obvious 
during emergency laparotomy. 
A second attempt at resection was carried out in 22 patients. In three, the fixation of the 
tumour to the pelvic side walls or the sacrum proved not to have been affected by the 
radiotherapy and the tumour was still considered unresectable. An adequate resection was 
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possible in 19 patients. In three, this resection was considered palliative because of the 
presence of tumour beyond the resection margins: a metastatic node in the groin requiring 
subsequent inguinal node dissection, carcinomatous deposits on the pelvic peritoneum, and 
hepatic metastases. The 16 remaining patients underwent a potentially curative resection. 
Ultimately, 36 patients underwent a resection subsequent to pre-operative radiotherapy; this 
was curative in 33 and palliative in three patients. The rectal resection used was an 
abdominoperineal operation in 26 patients and a modified Hartmann procedure in ten. 
Obvious tumour invasion, or suspicion thereof, was the reason to remove partially a 
portion of the genital tract en bloc with the rectum in ten female patients: uterus (N = 1), 
posterior vaginal wall alone (N = 3) or in combination with hysterectomy (N = 6). The 
presence of a rectovesical fistula necessitated a total exenteration in two male patients. The 
Dukes' and TNM classifications of the specimens are given in Table 1 .  
Table 1. Pathological stagmg of the 36 specimens 
Dukes' TNM 














'One specimen showed complete response 





There was no postoperative mortality in this patient group. Three patients had a major 
postoperative complication: presacral haemorrhage caused reversible kidney failure requiring 
haemodialysis in one patient, re-laparotomy was performed for small bowel ileus in one 
patient, and one patient developed acalculous cholecystitis, for which cholecystectomy was 
performed. The median duration of the postoperative hospital stay was 14 (range, 8 - 59) 
days. No radiotherapy related morbidity was detected during the postoperative period or 
during the follow-up. No delay in healing of the perinea! wound was identified when 
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abdominoperineal resection followed radiotherapy. The trial operation was continued as a 
formal resection in 1 7  patients and none of these patients developed local recurrence. 
FOLLOW-UP 
The follow-up of 36 pre-operatively irradiated patients was until 31 December 1992. The 
median time since entry into the study was 87 (range, 27 - 141) months. During follow-up, 
proportion 
I - - - - - 1 
0.8 
I 
' - - - - - - - - - - .. 
' - - - - - , 
0.6 
0.4 
0.2 - 30Gy(n = 1 5) 
- - 56Gy(n = 2 1 ) 
o� - - - - ----------�------� 
30 Gy 
56 Gy 
0 2 3 
1 3  
1 2  




Figure 3. The calculated local relapse free survival at 5 years of the 36 patients who 
underwent a resection; 21 patients received 56 Gy and 15 patients 30 Gy. The number of 
patients at risk for local recurrence on 3 1  December 1992 are presented along the X-axis. 
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pelvic recurrence became obvious in five patients, and one patient had concomitant distant 
metastases. A sixth patient died of causes not related to cancer and post-mortem disclosed 
an unsuspected pelvic recurrence. The local recurrence free survival at 5 years, calculated by 
the Kaplan-Meier method, was 720/o (950/o confidence interval 58-850/o; Fig. 3). Distant 
metastases without concomitant local recurrence developed in 1 1  patients. The calculated 
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Figure 4. The calculated survival of the 36 patients who underwent a resection. The number 
of patients at nsk on 31 December 1992 are presented along the X-axis. 
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DISCUSSION 
After potentially curative resection for rectal cancer the predominant relapse site is the 
pelvis, either alone or in combination with distant metastases.1-2 To prevent this dismal 
event, optimal surgery should be performed in those situations where it can cure on its 
own. In cases of advanced local disease, adjuvant therapy is indicated. For the evaluation of 
tumour stage, modern imaging techniques were not routinely used in this study. One of the 
reasons is that in the early part of this series we only had a first generation CT scanner at 
our disposal. 
Techniques such as computed tomographic (CT) scanning and magnetic resonance imaging 
(MRI) have until now not fully met expectations in the staging of primary rectal cancer. 
Butch et al. found MRI and CT scanning to be equally effective in staging rectal 
carcinoma. 8 These investigations failed to detect the extent of bowel wall penetration or 
tumour spread to normal size perirectal lymph nodes. While comparing the merits of MRI 
and surgical staging, Guinet et al. found a 730/o correlation, with only a 400/o sensitivity rate 
for detecting metastatic disease to pelvic lymph nodes.9 During the last decade 
endosonography has been widely advocated for the local staging of rectal cancer. When the 
tumour allows adequate positioning of the probe, endosonography has proved to be very 
reliable in identifying the depth of invasion into the wall of the rectum and therefore in 
discriminating between Tl, T2 and T3 tumours. Documentation of the extent of the 
infiltration outside the rectum, however, is incomplete and less reliable. 10 Previous reports 
on endosonography excluded stenotic tumours because they did not allow adequate 
introduction of the available instrument. However, evaluation of these stenosing tumours 
is important since they often involve adjacent structures and therefore may require 
additional radiotherapy. A group from Denmark may have solved this practical problem by 
using forward-looking endoprobes. 1 1 Notwithstanding progress in the technology of 
endosonography, it remains an operator dependent evaluation and the clinical guidelines 
derived from it need further analysis. 12 
In patients with advanced rectal cancer, especially in the male, transmural extension of the 
tumour in the anterior direction is very critical for the selection of the treatment strategy. 
Therefore, in this study, clinical and eventual surgical staging have been the cornerstones 
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of the assessment of local tumour infiltration, and selection of patients for a short (IO x 
3 Gy) or protracted (50-56 Gy) course of pre-operative radiotherapy. 
The reliability of digital examination and its value for the clinical staging of rectal cancers 
have already been highlighted. 13 The concept of surgical staging is not new; in the past, 
Goligher advised to 'proceed to laparotomy, however fixed the growth may seem clinically, 
before making a decision regarding the feasibility of its excision' . 14 Heald recommended 'the 
trial dissection' to investigate whether crucial planes between visceral and somatic structures 
are invaded by tumour. 15 
In this study, the patients with an advanced rectal cancer requmng peri-operative 
radiotherapy have been selected using clinical and surgical staging. Pre-operative 
radiotherapy has been used in these selected patients in an effort to improve local control 
in operable cases and increase resectability of fixed cancers. The vast majority of the 
patients who needed a protracted course of pre-operative radiotherapy first had a 
laparotomy for staging of the primary tumour by means of bimanual palpation and to 
fashion an end-colostomy on the descending colon. The total faecal diversion thus created 
made it easier for the patients to tolerate high-dose pre-operative radiotherapy.7 
After pre-operative radiotherapy, the pathological staging using the Dukes' classification and 
the TNM system provides equivocal information that can hardly be used as a prognostic 
indicator since it does not depict the original situation prior to the radiotherapy course. 
The downstaging caused by the pre-operative radiotherapy has been frequently mentioned 
in the literature. In Bergen, gross and microscopic changes after radiation therapy were 
compared with specimens from patients treated with primary surgery in a randomized 
prospective trial. A total of 138 patients who had pre-operative radiotherapy (31.5 Gy in 3.5 
weeks) and 13 1  patients who had primary surgery were analysed. Complete tumour 
regression was seen in six (4.4%) of the irradiated patients. The incidence of positive lymph 
nodes was 27.50/o in the specimen of the control group and 18.4% after pre-operative 
radiotherapy. 10 A substantial beneficial effect of pre-operative radiotherapy on the local 
recurrence rate was evidenced by the final data of the EORTC trial using a course of 34.5 
Gy in 15 daily doses. The local recurrence rates at 5 years were 350/o for the control group 
and 200/o for the combined modality treatment group. 17 
A recent publication by Krook and co-authors opens new avenues for the treatment of high 
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risk rectal cancer. By combining postoperative radiotherapy and chemotherapy (5-FU and 
Semustine) they showed a considerable beneficial effect on both the survival and local 
recurrence rate.18 
The latest publication from Sloan Kettering goes a step further in this direction, by 
combining pre-operative radiotherapy and pre-operative chemotherapy (Leucovorin-5-FU) 
in the treatment of unresectable rectal cancer.19 Patients with unresectable disease who 
received Leucovorin-5-FU and radiotherapy had a higher rate of pathologically complete 
response (200/o versus 0%) and a lower incidence of positive nodes (30% versus 64%) 
compared with those who received radiotherapy alone. These new treatment perspectives, in 
combination with advances in imaging techniques, could substantially facilitate selection 
of patients with a high risk of local recurrence for combined radiotherapy and 
chemotherapy, and improve their prospects of recurrence free survival. 
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SUMMARY 
Advanced rectal cancer 
Results are presented of 1 19 curative resections for rectal cancer in 47 women and 72 men. 
Throughout the study it has been the policy to remove part of the female genital tract when 
the rectal cancer was impinging on uterus and / or posterior wall. After a median follow-up 
of 7.5 years three relapses have occurred in women (110/o; 3-19) and 15 in men (P = 0,031). 
The survival at 5 years was 710/o for women (56-830/o) and 600/o for men (50-710/o; P < 0,05). 
The risk for distant metastasis was comparable suggesting an influence of local relapse rate 
on survival. 
The reduction of the local relapse rate coincides with the high percentage (19 / 47) of 
anterior extensions of surgery in women as compared to 2 / 72 anterior extensions in male 
patients. 
INTRODUCTION 
The incidence of local recurrence after surgery for rectal cancer varies between 4 and 50%1·4 
and may be due to inadequate resection, suture implantation of tumour cells from the 
lumen or residual metastatic disease in nodes of the pelvic side walls.5 Pre-operative radio­
therapy has been used to inhibit growth of malignant cells left behind after subsequent sur­
gery and postoperative treatment affects residual cancer cells in the pelvis exposed to radia­
tion. The debate about the choice between pre- and postoperative radiotherapy continues.6 
Radiotherapy and chemotherapy have also recently been investigated.7 The principal cause 
of pelvic recurrence is inadequate surgical excision for the circumferential spread of the 
tumour. Some say that "local recurrence is a surgical complication that can be almost 
entirely eliminated".8 Radicality requires wide lateral pelvic dissection and total mesorectal 
excision.9• 10 These techniques add nothing to the radicality in the anterior plane which may 
be compromised by circumferential tumour spread.5 Anterior extension has different conse­
quences for men and women. In men adequate anterior extension of the resection will com­
promise prostate and (or) bladder, and in women removing uterus and (or) posterior vaginal 
wall. It has been our policy in this institute to remove part or all of the female genital tract 
when a deeply invading rectal cancer was suspected of invading either of these structures. 1 1 
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If the extent of the surgical excision determines the risk of local recurrence, the women so 
treated should have a better prognosis than men. The results of curative surgery for rectal 
cancer in 1 19 patients are summarized in this study. 
PATIENTS AND METHODS 
Between 1 January 1978 and 31 December 1990 resection for rectal cancer was carried out 
with curative intent in 1 19 patients, 72 were men with a median age of 69 (range, 37 · 8�) 
years and 47 women with median age of 71 (range, 42 - 86) years. When, at laparotomy, the 
tumour was found to invade deeply in the anterior direction, surgery was extended to the 
female genital tract by means of excision of the posterior vaginal wall and / or uterus. In 
men total exenteration was only attempted in the case of a rectovesical fistula. The margins 
of the specimens were macroscopically free of tumour and distant metastases were not 
detected. 




50 - 56 Gy 
men N = 71 
50 (70.5%} 
10 (14%) 
1 1  (15.5%} 




Pre-operative radiotherapy was given to patients with deeply invading tumours or tumours 
with borderline resectability (Table 1). In 18 patients the tumour was judged to be resectable 
upon digital examination, but was deeply invading as evidenced by palpable ulceration or 
covered one half of the circumference. These patients received a course of radiotherapy (30 
Gy in 10 days) prior to surgery. Resection immediately followed this pre-operative radio­
therapy. Doubts about primary resectability were the indication for high-dose pre-operative 
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radiotherapy in 17  patients (50 - 56 Gy in 5 to 6 weeks). These patients with fixed or 
borderline resectable rectal cancers underwent an attempted resection 4 weeks after radio­
therapy. Patients did not receive postoperative radiotherapy. 
RESULTS 
Two of the 1 19  patients died shortly after surgery, leaving 1 17  patients with a curative 
resection available for review. 
Table 2. The type of rectal resection carried out in 1 17 male and female patients, 
available for follow-up. LAR = low anterior resection; APR = abdominoperineal resection. 
Surgical procedure men N = 71 
LAR 30 (420/o) 
APR 26 (37%) 
Hartmann procedure 15 (210/o) 




Table 2 details the procedures. Two male patients with a rectovesical fistula required total 
exenteration in one and a low anterior resection with excision of the bladder trigone in the 
other. In 19 out of 46 female patients extension of the rectal resection towards the genital 
tract was necessary to obtain tumour free margins. Seven women had undergone hyster­
ectomy. Five women had a fistula: in the cervix (1), the posterior fornix (1) or the lower 
part of the vagina (3). Obvious tumour invasion of the female genital tract or suspicion 
thereof prompted to perform concomitant hysterectomy (2), excision of the posterior 
vaginal wall (N "" 7) or a combination of hysterectomy and excision of the posterior vaginal 
wall (N "" 10). In two of these patients extension of the tumour towards the pelvic sidewalls 
required segmental resection of a ureter. 
Two peri-operative deaths were due to anastomotic leak and pulmonary embolism. Pelvic 
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sepsis developed in a patient with chronic leukaemia and transient renal insufficiency in 
another. Wound dehiscence occurred twice, small bowel ileus once. The postoperative 
hospital stay for the 117 surviving patients ranged from 8 to 84 (mean 15; average 19) days 
for women and 8 to 31 (mean 14; average 15.5) days for the men. 
The staging of the specimen was comparable for both sexes (Table 3). After high-dose pre­
operative radiotherapy no residual tumour could be found in one male patient (classified 
as Dukes' A). 
Table 3. Postoperative pathological staging of 1 17 patients available for follow-up. 
Dukes' classification A 
B 
C 








The results were analysed as of 3 1  December 1992 and the median time since study entry 
was 7.5 years. Survival was measured from surgery to death and time to local progression 
from surgery to local relapse. Local recurrence was tumour activity below the level of the 
innominate line and the sacral promontory, with or without concomitant distant 
metastases. 
STATISTICAL METHODS 
Curves of survival and incidence of local recurrence were drawn according to Kaplan and 
Meier. Differences were analysed using the Chi-square test. 
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FOLLOW-UP 
Advanced rectal cancer 
Follow-up ranged from 2 to 15 years. Three of 46 women and 15 of 71 men developed local 
recurrence (P = 0.031 ). The calculated risk of local recurrence at 5 years was 1 10/o for women 
(95% confidence interval 3- 19%) and 32% for men (95% confidence interval 22-43%; Chi­
square 3,287; Fig. 1). The localisation of the pelvic recurrences is summarized in Table 4. 
In six men the local recurrence was localised on the posterior aspect of the seminal vesicles 
and / or prostate. Despite the clinical (5 rectogenital fistulae) and pathological difference in 
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The calculated risk of local recurrence in the 1 17  patients available 
for follow-up. The numbers at risk on 3 1  December 1992 are found 
below the X-axis. 
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Table 4. Localisation of the pelvic recurrence as 
evidenced by CT-scan, sonography or laparotomy. 
Pelvic recurrence in men {N = 15) 
- after low anterior resection (4 / 30) 
- anastomotic recurrence {2) 
- hypogastric nodes (2) 
- after Hartmann procedure ( 6 / 15) 
- rectal stump (5) 
- hypogastric nodes (1) 
- after abdominoperineal resection (5 / 26) 
- hypogastric nodes {l) 
- pcrioneal wound {2) 
- pelvis (2) 
Pelvic recurrence in women (N = 3) 
- after Hartmann procedure ( 1  / 13) 
- rectal stump (1) 
- after abdominoperineal resection {2 / 16) 
• metastasis pelvic sidewall (1) 
- posterior vaginal wall {l) 
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extension of the resection (2 / 19) and those who did not (1 / 27, P = 0.56). Two women and 
five men had concomitant distant metastases. Distant metastases without pelvic recurrence 
were seen in eight women and 18 men (P � 0.31). The disease free survival at 5 years was 
610/o for women (confidence interval 41-740/o) and 500/o for the men (confidence interval 39-
610/o; Chi-square 4,087; P < 0.05). The survival after diagnosis of distant metastases, with or 
without concomitant local recurrence was comparable for both sexes. The calculated 12 
months survival after diagnosis of recurrent tumour activity was 100/o for men and 50/o for 
women. 
The calculated survival at 5 years was 710/o for women (950/o confidence interval 56-830/o) 
and 600/o for men (950/o confidence interval 50-710/o; Chi-square 4.41; P < 0.05; Fig. 2). 
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The calculated survival for the 1 17 patients available for follow-up. 
The numbers at risk on 3 1  December 1992 are found below the X­
axis. 
The difference in risk of local recurrence in men and women was statistically different but 
the risk of distant metastases was not different and the difference in the risk of death due 
to cancer must be caused by the higher local recurrence rate in the men. Gender and the 
ease to extend the resection in the anterior direction appear to be responsible for 
determining the risk of local recurrence. That this also diminishes the risk of death from 
cancer is an unusual finding in the literature 12 but as local recurrence is ultimately fatal its 
prevention could indeed have such an effect. A small survival advantage for women was 
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reported by the Swedish National Cancer Registry. 1 1  The equal incidence of distant 
metastases and comparable survival with metastatic disease indicate that the biological 
behaviour of rectal cancer is not influenced by gender. This study differs from others in 
that surgical technique varied in the anterior direction. In the group of 71 male patients, 
only two patients had an extended rectal resection. Of the 46 female patients 19 had 
extended surgery. We suggest that extension of the rectal resection in the anterior plane has 
been instrumental to the difference in local recurrence and survival between the sexes. 
Despite the clinical suspicion and pathological evidence of deep forward infiltration in 
these 19 female patients only two relapses occurred in this group, not significantly different 
from results in 27 patients without extension of surgery who had one local relapse. 
There are two major causes of local relapse of low rectal cancers: the lymphatic drainage 
and the anatomic topography. 
The lower 2 / 3 of the rectum drain mainly towards the rectal mesentery but in addition 
also drains towards the hypogastric artery via the middle rectal artery in the lateral 
ligaments. 14 15 This makes the lymphatic system of the lower rectum complex and difficult 
to manage by surgery. 
Inspection of the specimen of an abdominoperineal resection shows "a bare area" around 
the lower part of the rectum especially where the bowel is very close to the bony pelvis 
laterally and posteriorly and to the genital tract anteriorly. Here the surgeon is often unable 
to perform an adequate radical dissection. It is often impossible to leave even one centi­
meter of healthy tissue around the tumour once it has invaded the perirectal fat. In front 
of the rectum of the male Denonvilliers' fascia divides the subperitoneal pelvis into a dorsal 
rectal and a ventral urogenital department. For cancers located on the anterior aspect of the 
rectum, Denonvilliers' fascia acts as a barrier between the rectal and genital lymphatics, and 
prevents the cancer from spreading in the anterior direction.16• 17  This fascia is very thin and 
even perfect dissection in front of it does not warrant pelvic radicality when the cancer is 
deeply invading into the perirectal fat and infiltrates this fascia. 
In the female patient the internal genitalia are positioned as a barrier between the rectum 
and the bladder. Recently Enquist and Block performed dye studies of the rectal lymphatics 
in the female. Extensive lymphatic communications between the rectum and the female 
genitalia, and between the rectum and the peritoneum of the cul de sac were demonstrated. 
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These authors conclude that one can not perform a radical resection of the lower rectum 
and its local lymphatics if the posterior vaginal wall and the internal genitalia are not 
resected. 18 
The presence of the vagina between the rectum and the bladder offers an extra anterior 
clearance to achieve a wide anatomic dissection in the female. In the male this extra 
clearance provided by the dissection in front of Denonvilliers' fascia is futile when 
compared to en bloc excision of the posterior vaginal wall. The local recurrence pattern in 
our male patients suggests that anterior extension of surgery might reduce local relapse rate 
as 40% of recurrences occurred in that plane. This would however, be at the considerable 
cost of total exenteration, a decision at times difficult to make. 
In conclusion, the statistically significant difference in local recurrence rate in male and 
female patients, as found in this study probably originates from the extension of the 
surgery towards the genital tract in the latter. 
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SUMMARY AND CONCLUSIONS 
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This thesis is based on the experience with the treatment of patients with advanced rectal 
cancer in the section of Surgical Oncology, Department of Surgery, University Hospital of 
Groningen. The data from this study highlight the benefits of some special approaches to 
the treatment of rectal cancer. 
Chapter I, the introduction, emphasizes basic facts about the biologic behaviour of rectal 
cancer, its treatment, the problems of residual and recurrent rectal cancer in the pelvis and 
adjuvant therapy. 
Special attention is given to peculiar aspects of lymphatic pathways of the rectum and 
details of pelvic anatomy with consequences for the surgical treatment of rectal cancer. 
Modalities for local treatment of rectal cancer and their indications are briefly discussed. 
The technique of the rectal resection is elaborately depicted with emphasis on sharp 
dissection in the correct anatomical plane and adequate mesorectal excision. 
The origin of pelvic recurrence and the ways to avoid them are elaborately discussed. Early 
identification of infiltration in neighbouring structures, excision of invaded organs or parts 
thereof and the use of PVP Iodine in the lumen of the bowel are some very important 
technical details. 
The place of peri-operative radiotherapy in the treatment of rectal cancer and whether it 
should be administered prior or subsequent to the resection are elaborately discussed. In our 
institution we always favoured pre-operative radiotherapy. 
It appears from recent publications that postoperative chemotherapy courses based on 5-FU 
do have an effect on the survival after resection for colorectal cancer. In another 
publication the combination of pre-operative chemotherapy and radiotherapy increased the 
resectability rate of fixed tumours and the response rate was higher than in previously 
reported series with pre-operative radiotherapy alone. 
Chapter II focuses on the staging laparotomy, as a way to select patients with an 
unresectable or borderline resectable rectal cancer who may benefit from high-dose pre­
operative radiotherapy. The experience with 12 patients is described. The staging 
laparotomy, carried out in the modified lithotomy position, allowed to stage the abdominal 
cavity, to assess mobility and tumour size by means of bimanual palpation, and to fashion 
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an end colostomy at the level of the descending colon. A tumour dose of 50 or 56 Gy was 
administered in 5 to 6 weeks. The creation of total faecal diversion by means of the end­
colostomy, proved to be an excellent way for conditioning the patient for maximum 
tolerance during the protracted radiotherapy course. A second attempt to resect was 
scheduled 4 weeks after the end of the radiotherapy course. Eight patients ultimately 
underwent a curative resection. There was an obvious downstaging in the specimen. Three 
patients died during the follow-up due to haematogenic metastases without signs of pelvic 
recurrence. Five patients were alive without evidence of disease after an average follow-up 
of 34 (range, 20 - 64) months. It is suggested that local radicality benefitted from this 
strategy without originating mortality and with acceptable morbidity. 
Chapter III stresses the importance of the special characteristics of the female pelvis with 
regard to the treatment of rectal cancer. The rectum and the female genital tract have 
common lymphatic pathways. When a rectal cancer in the vicinity of the posterior vaginal 
wall or the posterior fornix, has been invading through the rectal wall, residual disease may 
be left behind if these structures are not removed en bloc with the rectum. This chapter 
reports about the experience with 20 female patients with advanced rectal cancer in whom 
rectal excision was combined with concomitant excision of the uterus and / or posterior 
vaginal wall. Six patients had a malignant fistula between the rectum and the female genital 
tract. In ten patients surgery was carried out subsequent to pre-operative radiotherapy with 
a tumour dose of 50 - 56 Gy in seven patients and 30 Gy in three. The resection was 
considered radical in 18  patients and the specimens were staged as Dukes' B in eight and 
Dukes' C in 10 patients. Three patients died within the follow-up period, due to 
intercurrent disease, without evidence of recurrence. Seven patients succumbed to distant 
metastases alone (N = 4) or to a combination of haematogenous metastases and pelvic 
recurrence (N = 3). Seven patients have been in follow-up without evidence of disease for 
an average of 91 (range, 39 - 143) months. One patient is alive with a pelvic recurrence 5 
years after surgery. A plea is made to extend the scope of the rectal resection into the 
anterior direction in female with a deeply invading cancer in the lower two thirds of the 
rectum. This extension of the surgery will not decrease the quality of life in these patients 
and may offer better cure rates. 
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Chapter IV draws the attention to a forgotten operation, the Hartmann procedure, a 
rectosigmoid resection without anastomosis. Between 1 January 1978 and 3 1  December 1989 
the extended Hartmann procedure was carried out in a selected group of 36 patients with 
primary adenocarcinoma of the rectum. 
The average age of the patients was 70 (range, 37 - 84) years. Ten patients had pre-operative 
radiotherapy because of deep infiltration and (or) fixation of the tumour. The Hartmann 
procedure was chosen because a low anterior resection could not warrant socially acceptable 
continence and an abdominoperineal resection was not needed. With the rectosigmoid 
resection without anastomosis (the Hartmann procedure) the hazards of low colo-rectal or 
cola-anal anastomosis, the compromised continence, and the discomfort of a perinea! 
wound were avoided. Eight of the 36 patients had hepatic metastases. The specimen of the 
remaining patients were staged as Dukes'A in two patients, B in nine and C in 17 patients. 
The postoperative morbidity was within acceptable limits and there was no hospital 
mortality. Twenty patients had a potentially curative resection prior to 3 1  December 1987, 
thus making them available for a follow-up of at least two years. Ten of these patients have 
been m follow-up for an average of 76 (mean 65; range, 28 - 123} months without evidence 
of disease. The remaining short rectal stump did not generate discomfort. The low local 
recurrence rate, notwithstanding the high percentage of deeply invading cancers, shows that 
the Hartmann procedure thus proves to be safe and an excellent alternative in selected cases. 
Chapter V describes how local control of advanced rectal cancer can ht promoted by 
selective use of pre-operative radiotherapy. It is generally accepted that peri-operative 
radiotherapy can decrease the local recurrence rate of deeply invading cancers seated in the 
lower two thirds of the rectum. The debate between the advocates of pre- and postoperative 
radiotherapy has been going on for years. Throughout the years we have been advocating 
pre-operative radiotherapy. During a 10-year period (1 January 1981-31 December 1990) 
clinical and (or) surgical staging were used by the same surgeon to select a group of 41 
patients with advanced rectal cancer for pre-operative radiotherapy. Fifteen patients with an 
advanced but resectable rectal cancer were subjected to a short course of radiotherapy (30 
Gy in 10 days) immediately followed by resection. High-dose pre-operative radiotherapy (50-
56 Gy in 5 weeks) was administered to 26 patients with borderline resectable or fixed 
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cancer. Adequate resection of the tumour was possible in 21 of these 26 patients four weeks 
after the end of the radiotherapy. Ultimately 36 patients thus underwent rectal resection, 
with curative (N = 33} or palliative (N = 3) intent subsequent to pre-operative radiotherapy. 
No radiotherapy related acute or late morbidity was seen. There was no postoperative 
mortality in this patient group. Three major complications occurred: presacral haemorrhage, 
small bowel ileus requiring re-laparotomy and acalculous cholecystitis. The mean duration 
of the postoperative hospital stay was 14 (range, 8 - 59} days. On 31 December 1992 the 
results were investigated retrospectively. The median time since entering into the study was 
87 (range, 27 - 141) months. During the follow-up pelvic recurrence was detected in six 
patients, one patient had concomitant distant metastases. The local recurrence free survival 
at 5 years calculated with the Kaplan Meier method was 720/o (950/o confidence interval 58-
850/o}. Distant metastases without pelvic recurrence developed in 1 1  patients. The calculated 
survival at 5 years was 450/o (950/o confidence interval 30.5-590/o). 
Chapter VI focuses on the difference between male and female patients with regard to the 
ease of extending the rectal resection anteriorly in female patients when tumour extension 
is thought to compromise part of the genital tract. The authors review the results of 1 19  
curative resections for rectal cancer performed between 1 January 1978 and 31 December 
1990. Throughout the study it has been the policy to remove part of the female genital tract 
when a deeply invading rectal cancer was invading or impinging on uterus and / or 
posterior vaginal wall. Two of the 1 19  patients died shortly after the surgery, thus leaving 
1 17  patients (71 male, 46 female) with a curative resection available for follow-up. Obvious 
tumour invasion of the female genital tract or suspicion thereof prompted to perform 
concomitant hysterectomy (2), excision of the posterior vaginal wall (7) or a combination 
of hysterectomy and posterior vaginal wall excision ( 10). Seven of the patients had a history 
of previous hysterectomy. Total pelvic exenteration was carried out in two male patients 
with a rectovesical fistula. Three out of 46 female, and 15 out of71 male patients developed 
a local recurrence (P - 0.031). The median time of follow-up was 7.5 (range, 2 - 15) years. 
The risk of local recurrence at 5 years was 1 10/o (950/o confidence interval 3-190/o) for the 
female patients and 320/o (950/o confidence interval 22-430/o} for the male patients (P < 0.05). 
The calculated five year survival was 710/o (950/o confidence interval 56-830/o) for the female 
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patients and 60% (95% confidence inte1Val 50-70%) for the men (P < 0.05). The incidence 
of distant metastases was comparable for both sexes. Pathological staging of the specimen, 
type of rectal resection and eventual pre-operative radiotherapy were proportionally 
distributed among male and female patients. The significant difference in local recurrence 
and su1Vival between the sexes therefore must be due to the extension in the anterior 
direction in one third of the female patients. In conclusion a plea is made for excision of 
the posterior vaginal wall and / or uterus in continuity with the rectum in female patients, 
and in men to contemplate total pelvic exenteration if radicality is compromised by 
anterior extension of the rectal cancer. 
CONCLUSIONS 
Some important guidelines for the treatment of rectal cancer can be deduced from this 
study. 
Till 30 years ago surgery was almost the only modality available for curative treatment of 
advanced rectal cancer. During the last decennia the application of peri-operative 
radiotherapy has been gaining increasing interest. The controversy between the advocates of 
pre-operative and postoperative radiotherapy has been going on for years. Recent literature 
pleads in favour of pre-operative radiotherapy. Chemotherapy has recently emerged as a 
promising adjunct to surgery and radiotherapy, with a beneficial effect on both the local 
recurrence rate and the su1Vival. 
The careful selection of the appropriate treatment strategy is the key to the adequate 
treatment of rectal cancer and the avoidance of local recurrence. Information about tumour 
localisation and infiltration into the vicinity is the cornerstone of the selection of the 
treatment strategy. The surgeon should carry out a good digital examination to asses the 
mobility and resectability of the tumour. It is very important to do a rigid proctoscopy to 
measure the distance between the tumour and the dentate line and to be informed about 
the relation of the tumour with the middle valve of Houston (the anterior peritoneal 
reflection). 
Primary resection can be carried out if the tumour is considered resectable upon digital 
examination and no signs of deep infiltration in the rectal wall can be detected. For deeply 
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infiltrating but resectable rectal cancers a short course of pre-operative radiotherapy (30 Gy 
in 10 days) should be given immediately followed by surgery. 
High-dose pre-operative radiotherapy (50 - 56 Gy in 5 to 6 weeks) should be administered 
when digital examination reveals that the tumour is deeply invading through the rectal wall 
and is tethered or fixed to the surrounding structures. The resection follows 4 weeks after 
the end of the radiotherapy course. These patients may benefit from a colostomy on the 
descending colon to avoid exacerbation of the rectal syndrome during the radiotherapy. 
Digital examination does not allow assessment of the resectability of cancers seated in the 
upper half of the rectum. In these cases a "trial operation" is carried out with the patient 
in the modified lithotomy position. Bimanual palpation allows to asses resectability and to 
decide either to go ahead with a primary resection or to fashion an end colostomy on the 
descending colon and postpone surgery till 4 weeks after pre-operative radiotherapy (50 - 56 
Gy in 5 to 6 weeks). 
The surgeon can make a choice between three procedures: the abdominoperineal resection, 
a sphincter-saving procedure and the Hartmann operation. This rectosigmoid resection 
without anastomosis is indicated when an abdominoperineal resection is not mandatory 
and the remaining rectal stump is too short to warrant socially acceptable continence. 
In female patients the surgeon should not hesitate to combine the rectal resection with 
hysterectomy and / or excision of the posterior vaginal wall when a deeply invading rectal 
cancer is impinging on these structures. In male patients with a deeply invading low rectal 
cancer extending into the anterior direction, total pelvic exenteration may be the only way 
to obtain radicality in the pelvis. 
In the near future it may become standard to include chemotherapy in the treatment 
strategy. The EORTC recently activated a trial to investigate the most appropriate place of 
the chemotherapy in relation with surgery and radiotherapy. Although adjuvant 
radiotherapy and / or chemotherapy open new avenues for the treatment of advanced rectal 
cancer, expert surgery remains its cornerstone. 
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In dit proefschrift wordt de ervaring beschreven van de behandeling van patienten met een 
rectumcarcinoom binnen de sectie chirurgische oncologie van het Academisch Ziekenhuis te 
Groningen. Enkele belangrijke aspecten van de behandeling van het rectumcarcinoom worden 
in dit proefschrift nader belicht. 
Hoofdstuk I, de inleiding, legt de nadruk op enkele basale aspecten van het rectumcarcinoom: 
het biologisch gedragspatroon en zijn relatie met de behandeling, de behandeling zelf, de plaats 
van de adjuvante behandeling en de problemen van het bekkenrecidief. De lymfedrainage van 
het rectum en de anatomie van het bekken worden besproken voor zo ver zij consequenties 
hebben voor de behandeling. Lokale therapieen en hun indicatie worden kort vermeld . De 
technische aspecten van de rectumresectie worden toegelicht. Benadrukt wordt de noodzaak 
tot scherpe dissectie, het volgen van het correcte anatomische vlak en zorgvuldige verwijdering 
van voldoende mesorectum. De emstige gevolgen van lokaal recidief en de maatregelen om 
het te vermijden komen aan de orde. Belangrijke feiten in dit verband zijn: het onderkennen 
van eventuele tumorinvasie in omgevende structuren, het hier aan aanpassen van de ingreep 
en het gebruik vanjodium als cytotoxisch middel. De peri-operatieve radiotherapie is belangrijk 
ter voorkoming van lokaal recidief. Voor- en nadelen van pre-operatieve en postoperatieve 
radiotherapie worden besproken. In de sectie chirurgische oncologie ging de voorkeur altijd 
uit naar pre-operatieve bestraling. Als gevolg van recente publicaties heeft de postoperatieve 
chemotherapie, met onder andere 5-FU een plaats gekregen in het behandelingsschema. Uit 
andere publicaties is gebleken dat pre-operatieve chemoradiotherapie de resectabiliteit verhoogde 
bij gefixeerde tumoren en de tumorregressie duidelijker was dan na pre-operatieve radiotherapie 
alleen. 
Hoofdstuk II is gewijd aan de zogenaamde exploratieve Iaparotomie. Het is daarmee mogelijk 
patienten te identificeren met gefixeerde of marginaal resectabele tumoren die niet in aanmerking 
komen voor primaire resectie maar eerst pre-operatieve radiotherapie dienen te ondergaan. 
De ervaring met 12 patienten wordt beschreven. Tijdens deze exploratieve laparotomie, uitgevoerd 
met de patient in glij ligging, worden door middel van een bimanueel toucher tumorafmeting, 
fixatie aan en ingroei in omgevende structuren onderzocht. Tevens wordt uitgebreide exploratie 
van de buikholte verricht ter detectie van eventuele afstandsmetastasen, waardoor radiotherapie 
illusoir zou zijn. De exploratieve laparotomie wordt meestel besloten met het aanleggen van 
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een eindstandig stoma op het linker colon. De voorbestraling die bier op volgt duurt 5 tot 6 
weken ( dosis 50-56 Gy). Door de aanwezigheid van bet stoma wordt deze langdurige bestral ing 
heel goed verdragen. De poging tot resectie wordt gepland 4 weken na het beeindigen van 
de voorbestraling . Acht van de twaalf patienten ondergingen uiteindelijk een in opzet curatieve 
resectie . Bij onderzoek van de operatiepreparaten werd een duidelijke tumorregressie gezien, 
zoals ook beschreven in de literatuur. Drie patienten overleden aan afstandsmetastasen zonder 
tekenen van lokaal recidief. Vijf patienten zijn nog in leven zonder aantoonbare tumor activiteit 
na een gemiddelde observatieduur van 34 (spreiding, 20 - 64) maanden. De resultaten suggeren 
dat deze strategie de kans op lokaal recidief verlaagt met acceptabele morbiditeit en zonder 
mortaliteit. 
Hoofdstuk III benadrukt bet bijzondere van de anatomie van bet vrouwelijke bekken en de 
consequenties voor de behandeling van het rectumcarcinoom. De gemeenschappelijke lymfebanen 
van bet rectum en bet vrouwelijk genitaal apparaat maken dat goede planning van de 
rectumresectie belangrijk is. Wanneer een diep infiltrerend rectumcarcinoom gelocaliseerd 
is in de nabijheid van de achterste fornix en/of de achterste schedewand dienen achterste 
schedewand en eventueel baarmoeder en bloc met het rectum te worden verwijderd. Bij beperkte 
chirurgie is het risico tumor achter te laten aanzienlijk. De ervaring met 20 vrouwelijke patienten 
met diep infiltrerend rectumcarcinoom wordt beschreven. Allen ondergingen een rectumresectie 
en bloc met baarmoeder en/of achterste schedewand. Zes patienten hadden een maligne fistel 
tussen rectum en genitaal apparaat. Bij tien patienten werd pre-operatieve radiotherapie gegeven, 
bij zeven patienten 50 tot 56 Gy en bij drie patienten 10 x 3 Gy. De resectie was in opzet 
curatief bij 1 8  patienten, bij acht patienten ging bet om een Dukes B tumor en bij tien om 
een Dukes C .  Drie patienten overleden gedurende de follow-up zonder tekenen van nieuwe 
tumoractiviteit. Zeven patienten overleden aan metastasering op afstand en drie hiervan hadden 
tevens een lokaal recidief. Na een gemiddelde follow-up van 9 1  (spreiding, 39 - 143) maanden, 
blijken nog zeven patienten in Ieven te zijn. Bij een dezer trad 5 jaar na de behandeling een 
bekkenrecidief op. In dit hoofdstuk wordt er voor gepleit bij vrouwelijke patienten met diep 
infiltrerend carcinoom in bet onderste 2/3 van het rectum de resectie naar ventraal uit te breiden 
door de achterste schedewand mee te reseceren. Hierdoor zal de kwaliteit van het )even niet 
worden benadeeld en wordt een grotere kans op curatie geboden. 
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Hoofdstuk IV behandelt de Hartmann procedure, een rectosigmoidresectie zonder anastomose, 
zoals tussen 1 januari 1978 en 3 1  december 1989 uitgevoerd bij 36 patienten met een primair 
rectumcarcinoom. De gemiddelde leeftijd van de patienten bedroeg 70 (spreiding, 37 - 84) 
jaar. Bij tien patienten werd de operatie voorafgegaan door radiotherapie op grond van diepe 
infiltratie en/of fixatie in de omgeving . Voor de Hartmann procedure werd gekozen wanneer 
rectumamputatie oncologisch niet noodzakelijk was maar van een anteriorresectie een dubieuze 
continentie werd verwacht. Door te kiezen voor een Hartmann procedure werden de risico's 
van naadlekkage, slechte continentie en de ongemakken van een perineale wond vermeden. 
Acht patienten bleken levermetastasen te hebben. Bij de overige 28 patienten werd het preparaat 
geclassificeerd volgens Dukes: Dukes A (N = 2), Dukes B (N = 9) en Dukes C (N = 17). 
De peri-operatieve morbiditeit was laag en er was geen mortaliteit. V oorafgaand aan 3 1  december 
1987 ondergingen 20 patienten een in opzet curatieve resectie zodat zij minstens 2 jaar in de 
follow-up zijn geweest. Tien van deze patienten zijn gemiddeld 76 (spreiding, 28 - 123) maanden 
gecontroleerd zonder dat nieuwe tumoractiviteit kon worden vastgesteld. De achtergebleven 
rectumstomp gaf geen problemen. Niettegenstaande het groot aantal Dukes C tumoren is het 
lokaal recidiefpercentage Iaag. De Hartmann procedure is dus niet nadelig voor de radicaliteit 
in het kleine bekken en voor bepaalde patienten een goed altematief voor rectumamputatie. 
Hoofdstuk V behandelt het selectieve gebruik van pre-operatieve radiotherapie voor het bevorderen 
van lokale radicaliteit bij de behandeling van diep infiltrerende rectumcarcinomen. Het gunstig 
effect van peri-operatieve radiotherapie op het verminderen van het lokaal recidief bij de 
behandeling van rectumcarcinomen gelegen in de distale 2/3 van het rectum is algemeen aanvaard. 
De discussie onder voorstanders van pre-en postoperatieve radiotherapie is nog gaande. Door 
de jaren heen zijn de auteurs voorstander geweest van pre-operatieve radiotherapie. Gedurende 
een periode van 10 jaar ( 1 januari 1981 - 31 december 1990) gebruikte de zelfde chirurg klinische 
en/ of chirurgische stagiering om een groep van 41 patienten met diep infiltrerend rectumcarcinoom 
te selecteren voor pre-operatieve radiotherapie. Bij 15 patienten met diep infiltrerend, maar 
resectabel rectumcarcinoom, werd gekozen voor kortdurende voorbestraling (30 Gy in 10 dagen) 
onmiddelijk gevolgd door resectie. Langdurige voorbestraling (50-56 Gy in 5 tot 6 weken) 
werd toegepast bij 26 patienten met een gefixeerde of marginaal resectabele tumor. Vier weken 
na het einde van de voorbestraling was adequate resectie van de tumor mogelijk bij 21 van 
deze 26 patienten. In totaal ondergingen dus 36 patienten een resectie van het rectum met curatieve 
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(N = 33) of palliatieve opzet (N = 3). Aan radiotherapie gerelateerde acute of late morbiditeit 
werd niet gezien. Evenmin werd mortaliteit gezien. Drie emstige postoperatieve complicaties 
deden zich voor: presacrale bloeding, ileus van de dunne dann, waarvoor laparotomie nodig 
was en acute acalculeuze cholecystitis. De gemiddelde postoperatieve opnameduur was 14 
(spreiding, 8 - 59) dagen. Op 31 december 1992 werden de resultaten retrospectief geanalyseerd. 
Op dat moment waren de patienten gemiddeld 79 (spreiding, 27 - 141) maanden in de studie 
opgenomen. Gedurende de follow-up werd een lokaal recidief vastgesteld bij zes patienten, 
een er van had tevens afstandsmetastasen. De lokaal recidief vrije overleving na 5 jaar, berekend 
met de Kaplan Meier methode was 72 % (95 % betrouwbaarheidsinterval 58-85 % ) . Bij 1 1  patienten 
werden afstandsmetastasen waargenomen die niet gepaard gingen met een lokaal recidief. De 
berekende 5-jaarsoverleving was 46 % (95 % betrouwbaarheidsinterval 30,5-59 %). 
Hoofdstuk VI brengt het verschil tussen mannen en vrouwen onder de aandacht. Voor de lokale 
radicaliteit is het bevorderlijk bij vrouwen de rectumresectie naar ventraal uit te breiden bij 
diep infiltrerende ventraal gelokaliseerde rectumcarcinomen. Tussen 1 januari 1978 en 31 
december 1990 werden in totaal 1 19 rectumresecties met curatieve opzet verricht. Gedurende 
deze periode werd bij vrouwen de baannoeder en/of de achterste schedewand verwijderd samen 
met het rectum wanneer het carcinoom deze structuren ingroeide of bedreigde door diepe 
infiltratie. Twee van deze 1 19 patienten overleden kort na de operatie zodat 1 17 patienten, 
71 mannen en 46 vrouwen, voor follow-up beschikbaar waren. Diepe tumorinfiltratie naar 
ventraal was de reden om en bloc met het rectum de baannoeder (2), de achterste schedewand 
(7) ofbaannoeder en achterste schedewand (10) te reseceren. Bij zeven patienten was vroeger 
al een hysterectomie gebeurd. Totale pelviene exenteratie gebeurde bij twee mannen met een 
rectovesicale fistel. Deze 1 17 patienten waren gemiddeld 7,5 (spreiding, 2 - 15) jaar in follow-up. 
Een lokaal recidief werd vastgesteld bij drie van de 46 vrouwen en bij 15  van de 71 mannen 
(P = 0,031). Het risico voor lokaal recidief na 5 jaar was 1 1  % (95 % betrouwbaarheidsinterval 
3-19 % ) voor de vrouwen en 32 % (95 % betrouwbaarheidsinterval 22-43 % ) voor de mannen 
(P < 0,05). De berekende kans op 5-jaarsoverleving was 71  % (95 % betrouwbaarheidsinterval 
56-83 %) voor de vrouwen en 60% (95 % betrouwbaarheidsinterval 50-71 %) voor de mannen 
(P < 0,05). Afstandsmetastasering werd bij mannen en vrouwen met de zelfde frequentie 
gezien. De pathologische stagiering van het preparaat, het type rectumresectie en de voorbestraling 
waren gelijkmatig verdeeld over beide geslachten. Het significante verschil in 5-jaarsoverleving 
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en lokaal recidief tussen mannen en vrouwen kan dan ook alleen te wijten zijn aan uitbreiding 
van de operatie naar ventraal bij 1/3 van het aantal vrouwelijke patienten. Daarom wordt dan 
ook er voor gepleit bij vrouwen de baarmoeder en of de achterste scbedewand in continuiteit 
met het rectum te verwijderen en bij mannen totale exenteratie te overwegen bij diepe infiltratie 
van het rectumcarcinoom in ventrale richting. 
CONCLUSIES 
Uit dit naonderzoek kunnen duidelijke adviezen voor de behandeling van het diep infiltrerende 
rectumcarcinoom worden afgeleid. 
Dertig jaar geleden was de chirurgie vrijwel de enige methode ter bebandeling van bet 
rectumcarcinoom. In de loop van de laatste decennia is de peri-operatieve radiotherapie aan 
de chirurgie toegevoegd. Tot voor kort bestond nog een controverse tussen de voorstanders 
van pre-operatieve en van postoperatieve radiotherapie. Uit recente literatuur en uit onze ervaring 
blijkt duidelijk dat de voorkeur uitgaat naar de voorbestraling. Recentelijk is gebleken dat 
chemotherapie een gunstig effect heeft op zowel de lokale radicaliteit als de overleving: pre­
operatief in combinatie met radiotherapie, en als nabehandeling . 
Voor het bereiken van lokale radicaliteit is het van kapitaal belang een goed onderbouwde 
behandelingsstrategie op te zetten vooraleer met de behandeling te beginnen. Deze strategie 
moet gebaseerd zijn op een goede beoordeling van de localisatie van de tumor en zijn uitbreiding 
in de omgeving. De chirurg zal zelf pre-operatief de mobiliteit en resectabiliteit van de tumor 
moeten bepalen. Tevens is het van groot belang voor de keuze van de resectie met de rectoscoop 
de exacte afstand tussen de tumor en de anus en de relatie van de tumor met de middelste 
klep van Houston te bepalen. 
Blijkt bij rectaal toucher dat de tumor goed mobiel is en niet diep infiltrerend dan komt hij 
in aanmerking voor primaire resectie . Bij diep infiltrerende maar nog goed resectabele tumoren 
is bet wenselijk een kort durende voorbestraling te geven van 30 Gy in 10 dagen en biema 
onmiddellijk tot resectie over te gaan. 
Is de tumor bij rectaal toucher niet mobiel ten opzichte van de omgeving en de resectabiliteit 
bijgevolg twijfelacbtig, dan is het aan te raden eerst te bestralen met 50 - 56 Gy in 5 tot 6 
weken. De resectie volgt dan vier weken na het einde van de voorbestraling. Voor sommige 
patienten met een laagzittend groot gefixeerd rectumcarcinoom kan worden overwogen een 
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stoma aan te leggen op het colon descendens om verergering van een bestaand rectaal syndroom 
tijdens deze langdurige voorbestraling te vermijden. 
Van tumoren gelegen in de bovenste helft van het rectum is de mobiliteit ten opzichte van 
de omgeving niet betrouwbaar te beoordelen met de toucherende vinger. In die gevallen adviseren 
we tot proefoperatie of "trial operation" over te gaan met de patient in glijligging. Blijkt bij 
bimanueel toucher dat van primaire resectie radicaliteit kan worden verwacht, dan wordt hiertoe 
overgegaan. lndien ingroei in de omgeving rede is om te twijfelen aan de radicaliteit van primaire 
resectie dan wordt het linker colon gekliefd en een eindstandig stoma aangelegd op het colon 
descendens. Na een voorbestraling van 5 tot 6 weken en een wachttijd van 4 weken volgt een 
nieuwe poging tot resectie. 
Voor de resectie kan worden gekozen tussen een rectumamputatie, een sfinctersparende operatie 
en een Hartmann procedure. Voor deze laatste wordt gekozen wanneer de rectumstomp te 
kort is om bij colorectale anastomose een sociaal acceptabele continentie te waarborgen, en 
de localisatie van de tumor het niet noodzakelijk maakt tot amputatie over te gaan. 
Bij vrouwelijke patienten met een diep infiltrerend carcinoom in de nabijheid van het genitaal 
apparaat mag niet geaarzeld worden baarmoeder en/of achterste schedewand en bloc met het 
rectum te reseceren. Bij de mannelijke patienten met een diep infiltrerend ventraal gelegen 
carcinoom mag niet worden vergeten dat totale exenteratie soms de enige mogelijkheid is om 
lokale radicaliteit te verkrijgen. 
In de toekomst zal het waarschijnlijk standaard worden chemotherapie in het behandelingsschema 
op te nemen. Recentelijk is een EORTC trial gestart om de meest geschikte plaats van de 
chemotherapie in de behandelingsstrategie van het rectumcarcinoom te onderzoeken. 
Hoewel adjuvante chemotherapie en/of radiotherapie belangrijke verbeteringen betekenen voor 
de behandeling van patienten met een diep infiltrerend rectumcarcinoom, is correcte en op 
hetjuiste tijdstip uitgevoerde chirurgische therapie de hoeksteen voor een adequate behandeling 
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